Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3007821	p-glu/0	mmol/l (mmol/l)	1314	1831	0.00%
3007821	p-gluk-0h	mmol/l (mmol/l)	547	756	0.00%
3007821	p-gluk-0	mmol/l (mmol/l)	197	264	0.00%
3007821	p-gluk0	mmol/l (mmol/l)	181	205	0.00%
3007821	p-gluk0	— (—)	112	134	100.00%	Distribution not available
3007821	p-gluk0h	MMOL/L (mmol/l)	61	69	0.00%
3007821	p-gluk-0	— (—)	26	26	100.00%	Distribution not available
3007821	p-glu/0	— (—)	25	25	100.00%	Distribution not available
3007821	p-glukoosi,0-näyte	mmol/l (mmol/l)	19	21	0.00%
3007821	p-gluk-0h	— (—)	10	10	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Contact with and exposure to communicable diseases

675

760

9.17

307.65

1.5

1.4

5.21

5.32

mmol/l

1.08

665

710

Persons with potential health hazards related to communicable diseases

706

897

8.03

307.65

1.5

1.4

5.26

5.41

mmol/l

1.74

695

840

Postpartum care and examination

274

140

12.72

210.71

1.5

1.2

4.94

5.63

mmol/l

7.72

269

134

Outcome of delivery

232

181

8.06

133.95

1.5

1.3

5.00

5.71

mmol/l

8.95

232

172

Other symptoms and signs involving the urinary system

135

188

7.36

91.89

1.3

5.91

5.98

mmol/l

0.16

135

176

Persons encountering health services for other counselling and medical advice, not elsewhere classified

606

1492

2.17

59.42

1.3

1.4

5.64

5.63

mmol/l

0.08

576

1406

Single delivery by forceps and vacuum extractor

122

119

6.20

56.89

1.7

1.3

4.95

5.84

mmol/l

7.64

116

113

Diabetes mellitus in pregnancy

299

710

2.70

49.27

1.8

1.3

5.34

5.08

mmol/l

2.68

281

685

Single delivery by caesarean section

130

158

4.75

45.96

1.5

1.3

5.06

5.93

mmol/l

8.54

123

150

Persons encountering health services in other circumstances, wide

559

1493

1.93

40.39

1.4

5.63

5.62

mmol/l

0.02

529

1407

Other maternal disorders predominantly related to pregnancy

382

1123

2.14

38.22

1.7

1.3

5.37

5.39

mmol/l

0.11

361

1066

Maternal care for other known or suspected fetal problems

203

442

2.91

38.21

1.8

1.4

4.92

5.23

mmol/l

5.20

196

421

Single spontaneous delivery

186

351

2.81

31.50

1.6

1.3

5.17

6.02

mmol/l

14.83

178

329

Type 2 diabetes, definitions combined, including avohilmo

469

1468

1.85

31.07

1.4

1.3

6.34

5.36

mmol/l

49.70

424

1411

Other nutritional deficiencies

380

1846

1.89

29.27

1.6

1.3

5.65

5.51

mmol/l

1.49

359

1753

False labour

213

542

2.46

29.23

1.6

1.4

5.11

5.34

mmol/l

1.46

208

516

Labour and delivery complicated by fetal stress [distress]

202

529

2.51

29.21

1.6

1.4

5.02

5.09

mmol/l

0.41

192

508

Care involving use of rehabilitation procedures

314

1417

2.00

28.63

1.3

5.91

5.69

mmol/l

1.70

300

1335

Delivery

179

352

2.69

28.08

1.5

1.3

5.15

6.01

mmol/l

18.23

170

330

Delivery, wide proxy

146

265

2.94

26.77

1.6

1.3

5.10

6.07

mmol/l

16.18

140

246

Obesity

355

1816

1.85

25.80

1.6

1.3

5.68

5.51

mmol/l

2.01

333

1727

Obesity and other hyperalimentation

356

1820

1.85

25.79

1.6

1.3

5.68

5.51

mmol/l

1.95

334

1731

Obesity due to excess calories

285

1455

1.97

25.36

1.6

1.4

5.65

5.48

mmol/l

1.50

266

1380

Obstructed labour due to malposition and malpresentation of fetus

167

635

2.46

25.29

1.6

1.4

5.04

5.26

mmol/l

2.92

161

608

Maternal care for known or suspected abnormality of pelvic organs

184

516

2.43

25.24

1.7

1.3

5.12

5.36

mmol/l

2.17

171

487

Type 2 diabetes, strict (exclude DM1)

447

1500

1.74

24.26

1.4

1.3

6.37

5.40

mmol/l

43.96

403

1440

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

265

819

2.05

24.06

1.6

1.5

4.99

5.08

mmol/l

0.54

259

783

Other obstetric conditions, not elsewhere classified

268

836

2.04

23.87

1.6

1.5

4.98

5.10

mmol/l

0.77

260

800

Type 2 diabetes, definitions combined

444

1495

1.73

23.82

1.4

1.3

6.37

5.40

mmol/l

43.49

400

1436

Supervision of high-risk pregnancy

120

245

2.97

23.32

1.6

1.3

5.19

5.74

mmol/l

5.66

114

233

Endocrine, nutritional and metabolic diseases

380

1064

1.81

22.76

1.5

1.3

5.70

5.17

mmol/l

7.37

355

1019

General examination and investigation of persons without complaint and reported diagnosis

301

808

1.94

22.48

1.3

1.4

5.62

5.54

mmol/l

0.37

281

763

Other special examinations and investigations of persons without complaint or reported diagnosis

301

808

1.89

20.83

1.4

5.66

5.54

mmol/l

0.89

288

763

Perineal laceration during delivery

142

485

2.39

19.71

1.6

1.4

5.02

5.00

mmol/l

0.05

134

463

Presence of other devices

114

437

2.58

19.62

1.3

5.98

mmol/l

0.00

106

412

Maternal care for known or suspected malpresentation of fetus

138

409

2.43

19.33

1.6

1.4

5.03

5.20

mmol/l

0.58

131

388

Other diseases of hard tissues of teeth

213

538

2.06

18.74

1.3

5.91

5.75

mmol/l

0.64

200

511

Disorders of lipoprotein metabolism and other lipidaemias

319

1099

1.77

18.73

1.3

6.10

5.87

mmol/l

2.15

297

1039

Antenatal screening

121

264

2.58

18.05

1.5

1.3

5.14

5.77

mmol/l

5.87

116

252

Disease of hard tissues of teeth, NOS

205

533

2.02

17.29

1.3

6.01

5.74

mmol/l

1.28

194

506

Maternal care for other conditions predominantly related to pregnancy

147

664

2.17

17.16

1.7

1.3

5.04

5.08

mmol/l

0.20

135

636

Speech therapy

120

528

2.28

15.98

1.2

1.3

6.12

5.87

mmol/l

0.84

114

498

Hyperlipidaemia, other/unspecified

138

574

2.17

15.90

1.3

1.2

6.27

6.10

mmol/l

0.59

129

542

Type 2 diabetes

433

1608

1.56

15.78

1.4

1.3

6.47

5.36

mmol/l

30.31

392

1546

Pure hypercholesterolaemia

279

1020

1.74

15.77

1.3

6.06

5.92

mmol/l

1.27

263

963

Maternal care related to the fetus and amniotic cavity and possible delivery problems

238

767

1.83

15.47

1.6

1.3

5.12

5.52

mmol/l

8.73

228

726

Complications of labour and delivery

312

1031

1.69

15.30

1.5

1.3

5.35

5.48

mmol/l

1.23

294

973

Long labour

152

630

2.06

15.08

1.7

1.4

5.17

5.23

mmol/l

0.34

146

602

Episodal and paroxysmal disorders

474

1594

1.51

14.52

1.3

1.4

5.69

5.49

mmol/l

2.57

447

1508

Gestational diabetes (for exclusion)

262

1051

1.72

14.52

1.7

1.4

5.41

5.09

mmol/l

5.05

243

1015

Sleep apnoea, including avohilmo

404

1578

1.55

14.46

1.3

5.88

5.69

mmol/l

2.79

379

1489

Covid-19 confirmed case

169

881

1.92

14.35

1.5

1.3

5.48

5.73

mmol/l

2.01

162

830

Dental operations

216

603

1.85

14.16

1.3

6.01

5.83

mmol/l

0.71

202

578

Dental caries, including avohilmo

265

784

1.73

14.15

1.3

5.83

5.69

mmol/l

0.70

252

746

Headache

324

1576

1.59

13.62

1.4

5.49

5.53

mmol/l

0.26

307

1498

Other (not insulin) diabetes medications

412

1589

1.52

13.61

1.5

1.3

6.49

5.42

mmol/l

28.52

374

1518

Fitting and adjustment of other devices

133

575

2.04

13.19

1.3

5.94

6.02

mmol/l

0.33

123

537

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

268

1419

1.64

13.06

1.4

5.39

5.35

mmol/l

0.20

256

1343

Diseases of pulp and periapical tissues and dental caries

236

694

1.75

13.00

1.4

1.3

5.85

5.67

mmol/l

0.84

223

662

Diabetes, varying definitions

438

1713

1.48

12.79

1.5

1.4

6.47

5.32

mmol/l

27.82

399

1642

Hypertension, essential

293

1020

1.63

12.71

1.3

6.05

5.62

mmol/l

6.03

281

960

Diseases of oral cavity, salivary glands and jaws

192

538

1.84

12.59

1.3

6.00

5.75

mmol/l

1.05

182

511

Caries of dentine, including avohilmo

286

892

1.64

12.58

1.4

1.3

5.83

5.65

mmol/l

1.02

271

847

Diabetes mellitus

439

1719

1.48

12.50

1.5

1.4

6.47

5.32

mmol/l

27.77

399

1649

Other dorsopathies, not elsewhere classified

439

1541

1.48

12.43

1.4

5.57

5.50

mmol/l

0.54

414

1456

Biguanides

387

1551

1.51

12.33

1.4

1.3

6.57

5.47

mmol/l

26.69

352

1481

Supervision of normal pregnancy

102

255

2.29

12.17

1.5

1.3

5.05

5.74

mmol/l

8.94

243

Abnormal findings on antenatal screening of mother

329

2.43

12.11

1.7

1.3

5.02

4.84

mmol/l

1.23

318

Excessive earwax

236

1297

1.65

11.91

1.2

1.3

5.92

5.78

mmol/l

1.33

228

1215

Insulin, intermediate and long-acting

1218

0.36

11.81

1.3

8.77

5.78

mmol/l

3.32

1148

Gestational [pregnancy-induced] hypertension

168

935

1.80

11.72

1.4

1.5

5.36

5.24

mmol/l

0.79

161

892

Other disorders of amniotic fluid and membranes

389

2.25

11.59

1.5

1.4

4.93

5.20

mmol/l

3.22

369

Persons encountering health services for specific procedures and health care

452

1850

1.44

11.55

1.3

1.4

5.80

5.51

mmol/l

4.15

426

1749

Pregnancy hypertension

244

1359

1.61

11.11

1.4

5.38

5.33

mmol/l

0.31

232

1293

Metabolic disorders

358

1446

1.49

10.72

1.3

6.01

5.68

mmol/l

4.56

338

1367

Sleep apnoea

345

1462

1.49

10.52

1.3

5.93

5.78

mmol/l

1.83

322

1381

Dorsopathies

437

1546

1.43

10.48

1.4

5.58

5.50

mmol/l

0.67

412

1460

Type 2 diabetes, wide definition

263

1052

1.58

10.45

1.4

1.3

6.76

5.61

mmol/l

18.31

236

1007

Hypertension

290

1056

1.55

10.44

1.3

6.03

5.59

mmol/l

5.98

278

992

Gingivitis and periodontal diseases

379

1333

1.47

10.42

1.3

5.71

5.63

mmol/l

0.57

347

1282

Hypertensive diseases

290

1057

1.55

10.40

1.3

6.03

5.59

mmol/l

6.01

278

993

Type of accident

129

692

1.87

10.25

1.4

5.61

5.63

mmol/l

0.06

124

654

Transient ischemic attack

165

761

1.73

9.79

1.2

1.3

5.96

6.07

mmol/l

0.69

153

720

Insulin, combination of fast acting with intermediate-acting or long-acting

1346

0.47

9.38

1.4

1.3

7.71

5.73

mmol/l

3.39

1274

Haemorrhage in early pregnancy

144

799

1.76

9.32

1.5

1.3

5.29

mmol/l

0.00

136

766

Diabetes medication

426

1785

1.40

9.14

1.5

1.3

6.52

5.35

mmol/l

27.69

388

1705

Dorsalgia

408

1540

1.41

8.96

1.4

5.55

5.50

mmol/l

0.34

379

1455

Persons encountering health services in other circumstances

168

1004

1.66

8.90

1.4

5.43

5.54

mmol/l

0.66

155

951

Spinal stenosis

157

683

1.70

8.64

1.3

1.2

6.13

6.09

mmol/l

0.10

148

635

Mouth breathing

142

826

1.72

8.64

1.2

1.3

5.88

5.85

mmol/l

0.15

132

784

Supplementary factors related to causes of morbidity and mortality classified elsewhere

134

769

1.75

8.61

1.4

5.62

5.64

mmol/l

0.06

128

727

Neurological diseases

366

1293

1.42

8.56

1.4

5.61

5.43

mmol/l

1.62

342

1227

Parasetamol

304

1052

1.46

8.25

1.4

5.51

5.44

mmol/l

0.40

287

1000

Other symptoms and signs involving the digestive system and abdomen

382

2.05

8.18

1.2

1.4

5.50

5.74

mmol/l

1.42

361

STROKE

190

805

1.59

8.05

1.3

5.89

5.83

mmol/l

0.40

176

769

Persons encountering health services in circumstances related to reproduction

188

791

1.60

8.05

1.4

1.2

5.47

5.98

mmol/l

8.10

181

738

Dental caries

432

1.95

8.04

1.3

5.75

5.68

mmol/l

0.14

413

Ischaemic heart disease, wide definition

236

963

1.51

7.82

1.2

1.3

6.06

6.04

mmol/l

0.10

216

910

Obesity related asthma

141

846

1.67

7.76

1.4

1.3

5.85

5.79

mmol/l

0.33

131

799

Covid-19 suspected case

642

0.28

7.76

1.4

4.98

5.43

mmol/l

1.56

609

Ischemic heart diseases

267

1083

1.47

7.70

1.2

1.3

6.03

5.95

mmol/l

0.53

245

1029

Symptoms and signs involving the urinary system

263

1359

1.46

7.69

1.3

5.97

5.75

mmol/l

1.68

257

1271

Angina pectoris

165

673

1.63

7.69

1.3

6.16

6.14

mmol/l

0.05

152

642

Symptoms and signs involving the circulatory and respiratory systems

421

1555

1.36

7.54

1.3

1.4

5.58

5.47

mmol/l

1.31

392

1489

Obesity, other/unspecified

162

1016

1.60

7.49

1.5

1.4

5.80

5.46

mmol/l

3.42

149

967

Spondylopathies

265

1077

1.46

7.33

1.2

1.3

6.03

5.80

mmol/l

1.79

247

1010

General symptoms and signs

438

1636

1.34

7.30

1.4

5.65

5.55

mmol/l

0.92

410

1555

Spondylosis

177

883

1.57

7.30

1.2

1.3

6.11

5.96

mmol/l

0.88

162

829

Hypertensive diseases (excluding secondary)

201

761

1.54

7.22

1.3

1.4

6.04

5.50

mmol/l

5.18

190

721

Insulin medication

1120

0.52

7.16

1.4

1.3

7.71

5.49

mmol/l

4.04

1070

Caries of dentine

388

1.94

7.08

1.2

1.3

5.73

5.69

mmol/l

0.08

371

Low back pain

316

1532

1.39

7.05

1.4

5.66

5.51

mmol/l

1.34

289

1448

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

328

1403

1.39

6.99

1.4

1.3

6.85

5.44

mmol/l

23.82

292

1345

Preterm labour and delivery

117

689

1.70

6.96

1.5

1.3

5.33

5.51

mmol/l

1.25

110

652

Pain in joint

231

967

1.47

6.78

1.5

1.4

5.61

5.57

mmol/l

0.21

216

921

Carpal tunnel syndrome

229

1365

1.46

6.77

1.4

1.3

5.80

5.77

mmol/l

0.17

208

1292

Persons encountering health services for examination and investigation

237

808

1.47

6.76

1.4

5.63

5.54

mmol/l

0.51

224

763

Lower back pain or/and sciatica

425

2000

1.32

6.69

1.3

1.4

5.64

5.57

mmol/l

0.50

392

1903

Disorders of the thyroid gland

385

1867

1.34

6.66

1.3

1.4

5.63

5.54

mmol/l

0.75

359

1778

Contraceptive management

140

602

1.63

6.65

1.4

1.2

5.52

5.94

mmol/l

5.18

133

564

Asthma, including avohilmo

463

1951

1.31

6.61

1.4

5.63

5.57

mmol/l

0.63

437

1847

Rotator cuff syndrome

205

948

1.49

6.61

1.2

1.3

5.91

5.93

mmol/l

0.12

190

893

Diseases of pulp and periapical tissues, including avohilmo

406

1577

1.33

6.55

1.4

5.72

5.51

mmol/l

1.81

378

1501

Depression

383

1920

1.33

6.54

1.4

5.66

5.56

mmol/l

0.78

363

1815

Constipation

316

1562

1.37

6.46

1.3

5.94

5.73

mmol/l

2.03

299

1471

Abnormalities of breathing

365

1554

1.34

6.39

1.3

1.4

5.72

5.47

mmol/l

4.23

337

1489

Mood disorders

401

1941

1.32

6.38

1.4

5.73

5.56

mmol/l

1.50

378

1835

Abdominal and pelvic pain

376

1407

1.34

6.37

1.3

1.4

5.68

5.60

mmol/l

0.53

349

1335

Mood [affective] disorders

400

1942

1.32

6.31

1.4

5.72

5.57

mmol/l

1.45

377

1836

Spontaneous abortion

238

1113

1.44

6.30

1.5

1.4

5.38

5.37

mmol/l

0.05

228

1049

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

341

1709

1.35

6.25

1.3

1.4

5.91

5.60

mmol/l

4.80

315

1621

Asthma, excluding more controls

306

1142

1.38

6.12

1.4

1.3

5.66

5.56

mmol/l

0.89

289

1088

Asthma

314

1183

1.37

6.10

1.4

1.3

5.66

5.58

mmol/l

0.61

297

1125

Chronic periodontitis, including avohilmo

361

1730

1.33

6.08

1.3

5.84

5.66

mmol/l

1.86

331

1641

Major coronary heart disease event

257

1092

1.41

6.06

1.2

1.3

5.99

5.98

mmol/l

0.04

234

1037

Periodontitis

361

1731

1.33

6.02

1.3

5.84

5.66

mmol/l

1.87

331

1642

Asthma (mode)

309

1193

1.36

5.82

1.4

1.3

5.63

5.58

mmol/l

0.36

293

1134

Symptoms and signs involving the digestive system and abdomen

371

1407

1.32

5.72

1.3

1.4

5.68

5.60

mmol/l

0.59

347

1335

Hard cardiovascular diseases

263

1121

1.39

5.69

1.3

5.97

5.90

mmol/l

0.49

241

1071

Gastrointestinal diseases

263

947

1.39

5.66

1.4

5.58

5.39

mmol/l

0.86

250

896

Conjunctivitis (acute, non atopic), including avohilmo

391

1813

1.30

5.62

1.4

1.3

5.50

5.64

mmol/l

1.64

373

1713

Other intervertebral disc disorders

303

1337

1.35

5.62

1.3

1.4

5.81

5.62

mmol/l

1.87

287

1257

Presence of cardiac and vascular implants and grafts

117

532

1.62

5.58

1.1

1.2

6.07

6.21

mmol/l

0.79

105

500

Shoulder lesions

253

1096

1.38

5.45

1.3

5.95

5.82

mmol/l

0.71

234

1033

Other neurological diseases

231

1287

1.39

5.39

1.3

5.84

5.82

mmol/l

0.09

216

1214

Coronary revascularization (ANGIO or CABG)

237

1032

1.40

5.38

1.2

1.3

6.01

5.98

mmol/l

0.12

214

980

Pre-eclampsia or poor fetal growth

171

1169

1.46

5.35

1.5

5.19

5.25

mmol/l

0.47

165

1114

Complications predominantly related to the puerperium

147

986

1.50

5.20

1.5

5.08

5.28

mmol/l

2.40

142

939

Gonarthrosis,primary

263

1166

1.36

5.14

1.3

1.2

6.02

5.98

mmol/l

0.16

241

1104

Migraine

235

1330

1.38

5.13

1.4

5.37

5.34

mmol/l

0.11

226

1264

Other disorders of veins

1013

0.54

5.09

1.2

1.3

5.89

5.84

mmol/l

0.10

950

Percutaneous Coronary Intervention

234

1032

1.38

5.00

1.2

1.3

6.00

5.98

mmol/l

0.10

211

980

Familial hypercholesterolemia, with ischemic heart disease

117

2.49

4.95

1.3

1.2

5.89

6.29

mmol/l

0.98

111

Diseases of the respiratory system

257

949

1.36

4.82

1.3

5.70

5.57

mmol/l

0.60

242

904

Other obstructed labour

176

2.17

4.77

1.4

1.3

5.52

5.36

mmol/l

0.31

166

Diabetes, insulin treatment (Kela reimbursement)

340

1562

1.30

4.77

1.4

1.3

6.86

5.51

mmol/l

23.46

304

1488

Other functional intestinal disorders

161

1015

1.44

4.74

1.4

5.78

5.70

mmol/l

0.27

153

955

Caries of enamel

369

1891

1.28

4.71

1.4

5.53

5.62

mmol/l

0.54

337

1796

Emergency coronary revascularization (for ACS)

247

1103

1.35

4.69

1.2

1.3

6.01

5.99

mmol/l

0.12

223

1049

Kela-code for severe mental illness

138

941

1.47

4.54

1.3

1.4

6.25

5.52

mmol/l

4.34

128

892

Diabetic neuropathy

226

0.22

4.54

1.2

1.3

6.28

6.68

mmol/l

—

204

Excluding asthma or asthma-COPD overlap

311

1193

1.31

4.53

1.3

5.67

5.58

mmol/l

0.41

289

1134

Sciatica+with lumbago

187

1190

1.39

4.53

1.3

5.52

5.67

mmol/l

1.31

173

1118

Other spirochaetal diseases

849

0.53

4.52

1.3

5.67

5.80

mmol/l

0.50

798

Other and unspecified nonorganic psychotic disorders

471

1.66

4.40

1.3

1.4

6.16

5.40

mmol/l

4.13

446

Hypothyroidism, other/unspecified

349

1803

1.27

4.38

1.3

1.4

5.61

5.52

mmol/l

0.69

323

1717

Lyme disease, including avohilmo

840

0.53

4.38

1.3

5.67

5.80

mmol/l

0.51

791

Lyme disease

840

0.53

4.38

1.3

5.67

5.80

mmol/l

0.51

791

Umbilical hernia

589

1.58

4.33

1.4

1.3

5.71

5.74

mmol/l

0.13

558

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

381

1943

1.26

4.32

1.3

1.4

5.55

5.61

mmol/l

0.39

360

1839

ILD differential diagnosis

309

1193

1.30

4.32

1.3

5.68

5.58

mmol/l

0.48

287

1134

Cholelithiasis, broad definition with cholecystitis

310

1601

1.29

4.31

1.4

1.3

5.86

5.67

mmol/l

1.96

293

1511

Mood disorders, excluding more controls

363

1685

1.27

4.30

1.4

5.75

5.54

mmol/l

2.13

340

1593

COPD differential diagnosis

309

1194

1.30

4.29

1.3

5.68

5.58

mmol/l

0.49

287

1135

Nerve, nerve root and plexus disorders

388

1857

1.26

4.28

1.4

1.3

5.77

5.61

mmol/l

2.21

362

1763

Other abnormal products of conception

185

876

1.39

4.23

1.5

1.4

5.14

5.23

mmol/l

0.70

178

836

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

166

742

1.41

4.15

1.4

5.64

5.49

mmol/l

1.00

158

704

Procreative management

474

1.58

4.15

1.6

1.3

5.38

5.96

mmol/l

5.24

450

Pain (limb, back, neck, head abdominally)

258

978

1.32

4.14

1.3

1.4

5.72

5.58

mmol/l

0.63

240

931

Diseases of oesophagus, stomach and duodenum

389

1839

1.25

4.12

1.3

1.4

5.87

5.57

mmol/l

3.12

372

1736

Pain in throat and chest

319

1477

1.28

4.12

1.3

1.4

5.81

5.50

mmol/l

4.61

295

1413

Cholecystectomy

245

1583

1.32

4.12

1.4

1.3

5.78

5.73

mmol/l

0.32

231

1490

Other acute lower respiratory infections

185

1289

1.37

4.11

1.3

1.4

5.57

5.65

mmol/l

0.41

177

1218

Spirochaetal infections, other/unspecified, including avohilmo

848

0.55

4.10

1.3

5.64

5.80

mmol/l

0.67

798

Cholelithiasis

296

1571

1.29

4.10

1.4

1.3

5.85

5.68

mmol/l

1.64

279

1482

Asthma (only as main-diagnosis), excluding more controls

270

1142

1.31

4.08

1.4

1.3

5.65

5.56

mmol/l

0.67

253

1088

Lumbar disc prolapse

222

1235

1.33

4.02

1.3

5.77

5.68

mmol/l

0.64

211

1163

Disorders of gallbladder, biliary tract and pancreas

347

1715

1.26

3.99

1.3

5.88

5.66

mmol/l

2.56

325

1620

Sleep disorders (combined)

408

1719

1.24

3.98

1.3

1.4

5.73

5.54

mmol/l

2.59

383

1633

Hypothyreosis and Thyroxine purchase for inclusion criteria

358

1872

1.25

3.98

1.3

1.4

5.61

5.54

mmol/l

0.49

329

1784

Rheumatism, unspecified

289

1.81

3.97

1.3

5.83

5.98

mmol/l

0.33

271

Other spirochaetal diseases, including avohilmo

864

0.57

3.96

1.3

5.64

5.80

mmol/l

0.71

811

Asthma (only as main-diagnosis)

274

1183

1.30

3.89

1.4

1.3

5.64

5.58

mmol/l

0.42

257

1125

Gastro-oesophageal reflux disease

229

1470

1.31

3.87

1.3

5.85

5.72

mmol/l

0.59

218

1380

Symptoms and signs involving the skin and subcutaneous tissue

266

1957

1.28

3.83

1.4

5.63

5.61

mmol/l

0.14

250

1853

Gonarthrosis [arthrosis of knee](FG)

227

987

1.32

3.80

1.3

6.01

5.95

mmol/l

0.24

210

934

Cerebrovascular diseases (FINNGEN)

438

1.54

3.80

1.3

5.84

5.74

mmol/l

0.46

418

Other sexually transmitted chlamydial diseases

235

0.30

3.72

1.4

1.5

5.09

5.15

mmol/l

—

225

Other pulmonary diagnosis

303

1193

1.27

3.71

1.3

5.66

5.58

mmol/l

0.35

282

1134

Varus deformity, not elsewhere classified

5.09

3.71

1.3

5.77

5.73

mmol/l

—

Hernia of abdominal wall

141

1007

1.40

3.70

1.4

1.3

5.94

5.84

mmol/l

0.38

128

947

Excessive, frequent and irregular menstruation

205

818

1.34

3.68

1.4

1.5

5.31

5.21

mmol/l

0.89

189

787

Antihypertensive medication - note that there are other indications

267

1082

1.29

3.66

1.4

1.5

5.52

5.10

mmol/l

4.91

250

1037

Hernia of abdominal wall, postoperative

408

1.63

3.62

1.5

1.3

5.96

5.85

mmol/l

0.22

383

Schizophrenia or delusion

113

779

1.45

3.61

1.3

1.4

6.16

5.57

mmol/l

4.32

104

736

Follow-up examination after treatment for conditions other than malignant neoplasms

158

762

1.38

3.60

1.4

5.34

5.50

mmol/l

1.32

150

721

Benign thyroid growths and nodules

109

693

1.46

3.58

1.3

5.94

5.79

mmol/l

0.46

103

657

Bronchitis

406

1994

1.22

3.57

1.4

5.50

5.60

mmol/l

1.02

381

1889

Triptan medication for migraine, single purchase ok

312

1687

1.25

3.55

1.4

5.44

5.51

mmol/l

0.37

296

1598

Migraine, single triptan purchase ok & required. ICD-code if available is included

312

1687

1.25

3.55

1.4

5.44

5.51

mmol/l

0.37

296

1598

Soft tissue disorders

383

1595

1.23

3.52

1.4

5.52

mmol/l

0.01

362

1511

Pregnancy with abortive outcome

289

1187

1.27

3.50

1.5

1.4

5.34

5.39

mmol/l

0.42

273

1121

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

137

985

1.39

3.49

1.6

1.4

5.42

5.31

mmol/l

0.54

132

943

Other symptoms and signs involving cognitive functions and awareness

134

848

1.40

3.48

1.2

1.3

5.82

5.95

mmol/l

0.91

124

805

Exclusions for E4_PCOS_CONSORTIUM

202

1647

0.76

3.46

1.4

5.64

5.42

mmol/l

2.35

191

1560

Gonarthrosis

192

812

1.34

3.46

1.3

5.90

5.93

mmol/l

0.17

176

773

Exposure to other specified factors

195

2185

0.76

3.43

1.3

1.4

5.55

5.57

mmol/l

0.07

190

2063

Other soft tissue disorders, not elsewhere classified

346

1591

1.24

3.43

1.4

5.62

5.52

mmol/l

1.01

326

1508

Dysphagia

505

1.55

3.39

1.2

1.3

5.67

5.91

mmol/l

1.42

478

Other benign neoplasms of uterus

2.59

3.38

1.1

1.3

5.98

5.75

mmol/l

0.65

Other diseases of upper respiratory tract

394

1683

1.22

3.37

1.3

1.4

5.66

5.62

mmol/l

0.23

371

1598

Unspecified lump in breast

404

1.61

3.37

1.3

1.4

5.50

5.55

mmol/l

0.20

378

Exposure to unspecified factor

256

2194

0.79

3.33

1.3

1.4

5.77

5.56

mmol/l

1.12

239

2078

Cystitis

334

1607

1.24

3.33

1.4

5.45

5.55

mmol/l

0.92

314

1525

Other diseases of urinary system

371

1702

1.22

3.32

1.4

5.55

5.57

mmol/l

0.18

352

1615

Dependent personality disorder

3.68

3.30

1.1

1.4

5.56

6.36

mmol/l

0.60

Other infestations, including avohilmo

3.97

3.30

1.0

1.2

5.75

6.71

mmol/l

0.64

Dental pulpitis, including avohilmo

362

1897

1.22

3.28

1.5

1.4

5.56

5.54

mmol/l

0.09

343

1793

Diseases of salivary glands

120

855

1.41

3.25

1.4

5.70

5.65

mmol/l

0.19

114

807

Leiomyoma of uterus

141

1077

0.73

3.23

1.3

1.4

5.88

5.62

mmol/l

2.21

132

1010

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

137

987

1.37

3.22

1.6

1.5

5.42

5.22

mmol/l

1.34

132

945

Asthma, unspecified (mode), excluding more controls

196

1072

1.31

3.21

1.3

5.71

5.59

mmol/l

1.09

182

1020

Other joint disorders

350

1487

1.23

3.21

1.4

5.51

5.46

mmol/l

0.27

329

1418

Bacterial infection, other or unspecified, including avohilmo

176

1089

1.33

3.21

1.3

6.13

5.80

mmol/l

1.65

159

1025

Schizophrenia, schizotypal and delusional disorders

111

782

1.42

3.20

1.3

1.4

6.16

5.57

mmol/l

4.17

102

739

Other disorders of urethra and urinary system

275

1529

1.25

3.16

1.3

1.4

5.63

5.56

mmol/l

0.50

263

1450

Coronary atherosclerosis

166

782

1.34

3.14

1.3

6.07

6.11

mmol/l

0.20

152

744

Chronic lower respiratory diseases

444

1956

1.20

3.12

1.4

5.68

5.55

mmol/l

1.25

420

1850

Abnormalities of heart beat

123

860

1.39

3.10

1.3

1.4

5.65

5.61

mmol/l

0.17

111

821

Other diseases of oesophagus

152

1.98

3.09

1.3

5.72

5.93

mmol/l

1.17

144

Complications of anaesthesia during pregnancy

10.52

3.01

2.0

1.6

5.04

5.34

mmol/l

—

Schizophrenia or delusion, excluding more controls

113

798

1.40

3.01

1.3

1.4

6.16

5.46

mmol/l

5.89

104

759

Asthma, unspecified (mode)

199

1112

1.29

3.00

1.3

5.71

5.61

mmol/l

0.89

185

1056

Acute upper respiratory infections

374

1857

1.21

3.00

1.4

1.3

5.57

5.63

mmol/l

0.39

352

1755

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

139

1780

0.75

2.99

1.5

1.4

5.42

5.48

mmol/l

0.24

128

1686

Meniscus derangement

167

838

1.32

2.96

1.3

6.04

5.89

mmol/l

0.40

154

800

Other female pelvic inflammatory diseases

435

1.55

2.94

1.2

1.4

5.39

5.52

mmol/l

0.56

408

Medical observation and evaluation for suspected diseases and conditions

204

808

1.29

2.89

1.3

1.4

5.73

5.54

mmol/l

1.33

188

763

Varicose veins

185

1079

1.30

2.88

1.3

5.76

5.95

mmol/l

1.81

174

1008

Schizophrenia

320

1.63

2.86

1.3

1.4

6.41

5.69

mmol/l

2.78

304

Hypothyroidism, strict autoimmune

294

1572

1.23

2.85

1.3

1.4

5.62

5.48

mmol/l

1.22

270

1499

Hypothyroidism (congenital or acquired)

131

536

1.37

2.83

1.4

1.5

5.38

4.95

mmol/l

4.02

119

516

Intestinal infectious diseases, including avohilmo, including avohilmo

409

1916

1.19

2.78

1.3

1.4

5.64

5.61

mmol/l

0.11

381

1815

Diverticular disease of intestine

200

974

1.28

2.75

1.3

1.2

5.92

6.01

mmol/l

0.63

189

914

Cardiovascular diseases

271

1163

1.24

2.74

1.5

5.32

5.21

mmol/l

0.95

258

1107

Enthesopathies of lower limb, excluding foot

532

1.47

2.73

1.3

5.57

5.76

mmol/l

1.06

502

Primary gonarthrosis, bilateral

135

844

1.34

2.73

1.3

1.2

6.01

6.10

mmol/l

0.43

124

796

Gout

358

1.54

2.71

1.2

6.16

6.23

mmol/l

0.17

339

408

1743

1.19

2.69

1.4

5.61

mmol/l

0.02

386

1646

Artrosis, including avohilmo

260

1150

1.24

2.68

1.3

5.83

5.67

mmol/l

0.80

238

1094

Medical abortion

269

1181

1.23

2.67

1.4

5.33

5.39

mmol/l

0.41

253

1115

Asthma (diagnoses ohter than nonallergic)

313

2098

1.21

2.63

1.4

5.63

5.57

mmol/l

0.57

297

1985

Hypothyroidism and >3 levothyroxin purchases

129

535

1.35

2.62

1.4

1.5

5.37

4.96

mmol/l

3.74

117

515

Hypothyroidism, levothyroxine purchases

129

535

1.35

2.62

1.4

1.5

5.37

4.96

mmol/l

3.74

117

515

Hypothyroidism, strict autoimmune, 3 medication purchases required

323

1804

1.20

2.61

1.3

1.4

5.64

5.52

mmol/l

0.98

297

1717

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

362

1923

1.19

2.56

1.3

1.4

5.76

5.54

mmol/l

2.94

337

1825

Psoas tendinitis

7.27

2.56

1.6

1.0

5.28

5.84

mmol/l

—

Lower leg

5.55

2.55

1.3

1.2

5.68

6.19

mmol/l

—

Mixed and other personality disorders

200

1.76

2.55

1.2

1.4

5.70

5.49

mmol/l

0.52

192

Polycystic ovarian syndrome, consortium definition

324

1546

1.20

2.55

1.4

5.62

5.33

mmol/l

4.64

302

1470

Allergic conjunctivitis

150

1861

0.77

2.54

1.5

1.4

5.45

5.48

mmol/l

0.13

139

1764

Other systemic involvement of connective tissue (FG)

613

1.41

2.52

1.3

1.4

5.43

5.77

mmol/l

2.83

584

Acetic acid derivatives and related substances

351

1.42

2.51

1.3

1.4

5.81

5.42

mmol/l

0.84

335

Bacterial infection, other or unspecified

151

985

1.29

2.43

1.2

1.3

6.17

5.84

mmol/l

1.85

137

929

Type 1 diabetes, strict (exclude DM2)

206

0.39

2.40

1.8

1.5

7.00

5.12

mmol/l

—

201

Type 1 diabetes, definitions combined

206

0.39

2.40

1.8

1.5

7.00

5.12

mmol/l

—

201

Congenital varicose veins

6.39

2.38

1.8

1.1

5.37

5.80

mmol/l

—

Postviral fatigue syndrome

3.70

2.38

1.3

1.6

5.02

5.43

mmol/l

—

Statin medication

220

999

1.24

2.36

1.3

1.4

6.02

5.39

mmol/l

5.56

202

952

Neurological diseases, wide definition

120

448

1.35

2.35

1.4

1.5

5.40

5.01

mmol/l

4.10

113

433

Unspecified mental disorder

142

1100

1.29

2.33

1.3

1.4

6.21

5.49

mmol/l

4.43

132

1044

COPD/asthma related infections

375

1595

1.18

2.32

1.4

5.61

5.58

mmol/l

0.18

356

1513

COPD/asthma/ILD related infections

375

1595

1.18

2.32

1.4

5.61

5.58

mmol/l

0.18

356

1513

Thyrotoxicosis with toxic multinodular goitre

2.05

2.31

1.3

1.4

6.04

5.95

mmol/l

0.08

Acute upper respiratory infections of multiple and unspecified sites

282

1713

1.20

2.31

1.4

5.38

5.59

mmol/l

2.76

262

1626

Urinary track infection

281

1167

1.21

2.28

1.4

5.46

5.31

mmol/l

1.03

266

1110

Other benign neoplasm of uterus: Corpus uteri

4.68

2.28

1.0

1.2

6.32

5.41

mmol/l

—

Persons encountering health services for specific procedures, not carried out

186

0.38

2.27

1.3

1.4

5.24

5.64

mmol/l

—

178

Spirochaetal infections, other/unspecified

169

0.35

2.27

1.2

1.3

5.19

5.89

mmol/l

—

160

Other and unspecified tonsillitis

148

959

1.28

2.27

1.5

1.4

5.39

5.29

mmol/l

0.34

141

920

333

1.54

2.26

1.5

5.35

5.44

mmol/l

0.29

318

Disorders of synovium and tendon

187

1273

1.25

2.25

1.3

1.4

5.60

5.63

mmol/l

0.17

180

1205

Diseases of the musculoskeletal system and connective tissue

216

876

1.24

2.24

1.4

5.52

5.40

mmol/l

0.45

204

833

Provisional assignment of new diseases of uncertain etiology

186

1484

1.24

2.24

1.5

1.4

5.45

5.56

mmol/l

0.68

174

1405

Hand

5.66

2.22

1.8

1.1

4.92

8.30

mmol/l

—

Benign neoplasm of colon, rectum, anus and anal canal

168

1128

1.26

2.22

1.2

1.3

5.98

6.01

mmol/l

0.16

163

1053

Gout, idiopatic and unspecified

375

1.50

2.21

1.2

6.16

6.20

mmol/l

0.08

350

Arthropathies

347

1487

1.18

2.21

1.4

5.46

mmol/l

0.03

322

1418

Codes for special purposes

186

1487

1.24

2.20

1.5

1.4

5.45

5.56

mmol/l

0.69

174

1408

Menorrhagia

158

691

1.28

2.19

1.4

1.5

5.39

5.28

mmol/l

0.84

150

663

Other specific joint derangements/joint disorders

283

1475

1.20

2.19

1.4

5.58

5.45

mmol/l

1.18

266

1409

Other congenital malformations of peripheral vascular system

3.37

2.18

1.9

1.4

5.38

6.47

mmol/l

—

Amenorrhoea

322

0.49

2.17

1.5

1.6

5.21

5.03

mmol/l

0.41

313

Postmenopausal bleeding

253

1.45

2.14

1.3

6.02

5.98

mmol/l

0.11

237

Asthma/COPD (KELA code 203)

343

1955

1.17

2.14

1.4

5.64

5.55

mmol/l

1.06

326

1849

Superficial injury of wrist and hand

578

1.39

2.13

1.4

1.5

5.38

5.43

mmol/l

0.19

551

Poisoning by medicine, drug-induced

3.23

2.10

1.4

1.3

6.02

6.67

mmol/l

—

Other diseases of anus and rectum

628

1.37

2.10

1.3

5.79

5.91

mmol/l

0.49

592

Chronic apical periodontitis

398

1926

1.16

2.09

1.4

5.72

5.54

mmol/l

2.22

367

1835

Inflammatory diseases of female pelvic organs

277

1593

1.19

2.08

1.4

5.39

5.38

mmol/l

0.06

260

1512

Asthma, hospital admissions , main diagnosis only

286

2103

1.18

2.07

1.4

5.63

5.56

mmol/l

0.53

269

1991

Complications following infusion, transfusion and therapeutic injection

3.53

2.06

1.4

1.2

5.28

7.18

mmol/l

—

Other enthesopathies

719

1.34

2.04

1.4

1.3

5.90

5.83

mmol/l

0.29

682

Dentofacial anomalies [including malocclusion]

277

1828

1.19

2.04

1.4

5.35

5.51

mmol/l

2.20

259

1733

Acute bronchitis

128

981

1.28

2.01

1.3

1.4

5.58

5.70

mmol/l

0.71

122

925

Parapsoriasis

2.83

2.00

1.4

6.13

6.31

mmol/l

—

Other chronic obstructive pulmonary disease, including avohilmo

129

827

1.28

1.99

1.3

1.2

6.27

6.06

mmol/l

0.56

122

779

Arthrosis

211

949

1.22

1.98

1.3

5.81

5.82

mmol/l

0.06

194

903

Zoster [herpes zoster], including avohilmo

156

1208

1.25

1.96

1.3

5.71

5.79

mmol/l

0.40

148

1132

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

364

0.56

1.96

1.4

5.50

5.59

mmol/l

0.18

346

Convergence insufficiency and excess

2.76

1.94

2.1

1.4

4.88

5.28

mmol/l

—

Fall on same level

328

2033

0.86

1.94

1.4

5.75

5.54

mmol/l

1.42

307

1927

Asthma-related infections

193

1548

1.22

1.93

1.4

5.60

mmol/l

0.03

186

1464

Asthma, hospital admission 2, infections

193

1548

1.22

1.93

1.4

5.60

mmol/l

0.03

186

1464

Any death

104

944

0.77

1.90

1.1

1.3

6.22

6.06

mmol/l

0.81

887

Previous suicide attempt

3.22

1.88

1.1

1.3

5.24

6.62

mmol/l

—

Triptan medication for migraine, min. 3 purchases

248

1561

1.19

1.88

1.4

5.37

5.38

mmol/l

0.03

233

1488

Symptoms and signs involving the nervous and musculoskeletal systems

182

1495

1.22

1.86

1.4

5.85

5.69

mmol/l

1.33

160

1420

Gout, FINNGEN

454

1.40

1.86

1.2

6.16

6.24

mmol/l

0.18

427

Recurrent or chronic depression

160

896

1.24

1.85

1.3

1.4

5.73

5.44

mmol/l

1.35

150

852

Other arthrosis

147

787

1.25

1.85

1.3

5.86

5.96

mmol/l

0.67

141

750

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

135

533

1.27

1.84

1.4

5.67

5.34

mmol/l

1.12

130

513

Chronic periodontitis, complicated

160

1266

1.23

1.84

1.3

5.92

mmol/l

0.03

147

1192

Other diseases of intestines

382

1856

1.15

1.79

1.4

5.64

5.52

mmol/l

1.02

365

1757

Pain in limb

291

1584

1.17

1.77

1.4

5.62

5.52

mmol/l

0.89

270

1503

Malignant neoplasm of breast, including Hilmo

777

0.77

1.77

1.2

1.3

5.76

5.73

mmol/l

0.11

733

Malignant neoplasm of breast, HER2-negative, including Hilmo

777

0.77

1.77

1.2

1.3

5.76

5.73

mmol/l

0.11

733

Malignant neoplasm of breast

752

0.76

1.76

1.2

1.3

5.83

5.74

mmol/l

0.37

708

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.94

1.72

1.6

1.4

6.16

6.76

mmol/l

—

Other systemic involvement of connective tissue

671

1.31

1.72

1.3

5.43

5.76

mmol/l

2.77

629

Malignant neoplasm of breast, HER2-negative

749

0.77

1.71

1.2

1.3

5.83

5.74

mmol/l

0.36

706

Rheumatoid arthritis, including avohilmo

916

0.74

1.70

1.3

5.69

5.83

mmol/l

0.40

864

Other/unspecified dorsalgia

120

942

1.26

1.70

1.4

5.77

5.64

mmol/l

0.61

114

891

Disorders of choroid and retina

160

1362

0.82

1.69

1.2

1.3

5.98

5.90

mmol/l

0.31

152

1275

Injury, poisoning and certain other consequences of external causes

208

870

1.20

1.68

1.4

5.63

5.47

mmol/l

0.62

198

821

Other bacterial diseases, including avohilmo

332

1803

1.15

1.66

1.3

1.4

5.96

5.60

mmol/l

4.38

308

1705

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

394

0.61

1.66

1.3

1.4

5.42

5.58

mmol/l

0.35

372

Disturbances of skin sensation

107

842

1.27

1.66

1.4

5.44

5.52

mmol/l

0.38

101

802

Used for control exclusion in common control thyroid runs

375

1656

1.14

1.66

1.4

5.76

5.51

mmol/l

1.92

349

1578

Other heart diseases

151

798

1.23

1.65

1.3

1.4

5.64

5.47

mmol/l

1.20

144

759

Systemic connective tissue disorders

108

852

1.27

1.64

1.3

5.49

5.76

mmol/l

2.20

103

799

Lung diseases due to external agents

226

0.49

1.64

1.2

1.3

5.88

6.06

mmol/l

0.26

212

Tonsillectomy and adenotomy

226

1332

1.18

1.64

1.4

5.33

5.34

mmol/l

0.03

212

1273

Abnormal weight loss

181

1.61

1.63

1.4

1.3

5.50

5.90

mmol/l

1.18

173

Acute nasopharyngitis (common cold)

219

1.54

1.62

1.3

1.4

5.50

5.75

mmol/l

0.67

211

Gout due to impairment of renal function

3.60

1.62

1.0

1.2

6.02

7.77

mmol/l

—

Cervicobrachial syndrome

531

1.34

1.60

1.3

5.57

5.73

mmol/l

0.68

502

Cardiovascular diseases (excluding rheumatic etc)

255

1248

1.17

1.60

1.4

1.5

5.48

5.24

mmol/l

2.87

243

1187

Excessive vomiting in pregnancy

230

1.53

1.59

1.4

1.3

5.45

5.13

mmol/l

0.26

217

Benign neoplasm: Other and unspecified parts of small intestine

3.02

1.58

1.3

1.1

5.97

6.97

mmol/l

—

Thyroiditis, ILD-related definition

321

1.44

1.57

1.2

1.4

5.37

5.49

mmol/l

0.30

306

Any reimbursement code in KELA

248

1062

1.17

1.55

1.5

1.4

5.67

5.14

mmol/l

3.98

235

1025

Other retinal disorders

115

1087

0.80

1.55

1.3

6.01

5.92

mmol/l

0.30

109

1017

Foreign body in ear

2.44

1.54

1.8

1.4

5.60

6.33

mmol/l

—

Hernia

286

1649

1.15

1.53

1.3

5.87

5.71

mmol/l

1.36

269

1555

Chronic diseases of tonsils and adenoids

284

1553

1.15

1.53

1.4

5.43

5.56

mmol/l

1.15

264

1474

Marginal zone B-cell lymphoma

3.36

1.53

1.4

1.1

5.30

7.38

mmol/l

—

Disorders of vestibular function (Vertigo)

130

1030

1.23

1.52

1.3

5.77

5.88

mmol/l

0.76

121

969

Pleural plaque

140

0.43

1.52

1.3

1.2

5.77

6.39

mmol/l

—

133

Soft tissue disorders related to use, overuse and pressure

580

1.31

1.51

1.2

1.3

5.87

5.91

mmol/l

0.12

543

Explicit bacterial Sepsis, including avohilmo

204

0.49

1.48

1.4

6.62

5.86

mmol/l

—

195

Haemorrhoids and perianal venous thrombosis

744

1.27

1.47

1.2

1.3

5.85

5.86

mmol/l

0.03

697

Wet age-related macular degeneration

234

1.48

1.46

1.3

1.2

6.23

6.28

mmol/l

0.08

218

Periapical abscess

142

1173

1.21

1.46

1.3

1.4

5.67

5.76

mmol/l

0.57

130

1111

Hypotension due to drugs

3.14

1.44

1.2

1.1

6.54

7.60

mmol/l

—

HSIL lesion of the vagina

2.75

1.44

1.2

1.4

5.42

5.48

mmol/l

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

123

1496

0.82

1.43

1.3

1.4

5.90

5.73

mmol/l

0.57

116

1406

Diseases of inner ear

149

1186

1.20

1.42

1.3

5.78

5.87

mmol/l

0.68

137

1116

Oral corticosteroids

369

1920

1.13

1.41

1.3

1.4

5.72

5.58

mmol/l

1.35

344

1823

Cardiac arrhythmias

204

1114

1.17

1.41

1.3

1.4

5.60

5.26

mmol/l

4.71

198

1071

Tularaemia, including avohilmo

2.43

1.39

1.0

1.2

5.64

6.62

mmol/l

—

Localized swelling, mass and lump of skin and subcutaneous tissue

783

1.25

1.39

1.3

5.83

5.77

mmol/l

0.32

739

Autoimmune diseases excluding thyroid diseases

285

1761

0.88

1.38

1.4

5.87

5.53

mmol/l

2.00

268

1676

Opioids

363

1664

1.13

1.37

1.4

5.62

5.48

mmol/l

1.59

340

1581

Assault by blunt object

2.62

1.37

1.0

1.3

5.68

6.76

mmol/l

—

Myasthenia gravis

2.62

1.37

1.5

1.2

5.37

6.80

mmol/l

—

Faecal incontinence

166

1.57

1.37

1.3

5.71

5.99

mmol/l

0.66

156

Other disorders of ear

281

1589

1.14

1.37

1.3

5.82

5.75

mmol/l

0.47

260

1500

Ankle and foot

2.97

1.36

1.8

1.2

5.54

7.14

mmol/l

—

Acquired absence of limb

2.97

1.36

1.0

1.2

7.28

7.30

mmol/l

—

Explicit bacterial Sepsis

197

0.51

1.36

1.4

6.62

5.87

mmol/l

—

188

Other symptoms and signs involving the nervous and musculoskeletal systems

136

1129

1.21

1.35

1.4

5.77

5.65

mmol/l

0.67

119

1074

Finngen Rheumatological endpoints

338

1699

1.13

1.35

1.3

1.4

5.61

5.52

mmol/l

0.84

317

1620

Injuries to the knee and lower leg

415

2010

1.12

1.35

1.4

5.67

5.56

mmol/l

0.99

391

1901

Diseases of the ear and mastoid process

406

1820

1.12

1.34

1.4

5.51

5.56

mmol/l

0.44

381

1729

Other abnormal uterine and vaginal bleeding

486

1.27

1.34

1.3

1.5

5.88

5.42

mmol/l

2.87

465

Unspecified haematuria

632

1.25

1.33

1.2

1.3

6.05

6.00

mmol/l

0.14

590

Dermatophytosis, including avohilmo

212

1795

1.16

1.31

1.4

5.70

5.64

mmol/l

0.29

201

1697

Anxiety (asthma-related co-morbidities)

230

1517

1.15

1.31

1.5

1.4

5.67

5.43

mmol/l

1.61

222

1440

Fissure and fistula of anal and rectal regions

550

1.29

1.31

1.5

1.3

5.77

5.80

mmol/l

0.09

520

Guttate psoriasis

2.52

1.30

1.2

1.4

5.33

6.41

mmol/l

—

Pyogenic granuloma

2.37

1.29

1.5

5.14

6.25

mmol/l

—

150

1253

1.19

1.29

1.4

5.50

5.54

mmol/l

0.28

144

1184

Tularaemia

2.79

1.29

1.0

1.2

5.26

6.92

mmol/l

—

Chronic suppurative otitis media, including avohilmo

145

1.59

1.28

1.3

1.4

6.22

5.75

mmol/l

0.65

139

Major coronary heart disease event excluding revascularizations

131

716

1.21

1.27

1.2

1.3

6.12

6.15

mmol/l

0.11

117

685

Nonspecific lymphadenitis

122

1.64

1.27

1.3

1.4

5.65

5.77

mmol/l

0.13

117

Ulcer of lower limb, not elsewhere classified

243

0.58

1.27

1.1

1.3

6.84

6.10

mmol/l

0.44

229

Autoimmune diseases excluding thyroid diseases, strict definition

278

1714

0.88

1.26

1.4

5.88

5.52

mmol/l

2.12

261

1636

Certain zoonotic bacterial diseases

2.41

1.24

1.0

1.2

5.32

6.71

mmol/l

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

107

877

1.22

1.24

1.3

1.4

5.76

5.69

mmol/l

0.20

100

825

Premature separation of placenta [abruptio placentae]

1.98

1.22

1.7

1.5

4.77

5.47

mmol/l

2.52

Melanoma in situ of trunk

2.65

1.22

1.6

1.2

5.94

7.34

mmol/l

—

Marginal zone B-cell lymphoma, including Hilmo

2.64

1.22

1.4

1.1

5.30

7.26

mmol/l

—

Coxibs

353

1.26

1.21

1.4

5.66

5.42

mmol/l

1.29

337

Other and unspecified vascular occlusions

156

1.54

1.20

1.3

1.2

6.50

6.19

mmol/l

0.27

146

Implicit viral Sepsis, including avohilmo

655

1.25

1.18

1.3

5.75

5.78

mmol/l

0.09

619

Benign neoplasm: Duodenum

2.11

1.18

1.6

1.2

6.25

6.53

mmol/l

—

Female genital prolapse

411

1.25

1.18

1.3

1.4

5.82

5.57

mmol/l

0.56

391

Any event in cancer register

262

1730

0.88

1.18

1.3

1.4

5.79

5.54

mmol/l

3.37

250

1635

Streptococcal septicaemia, including avohilmo

170

0.53

1.18

1.2

1.3

6.77

5.96

mmol/l

—

159

Dizziness and giddiness

234

1597

1.14

1.17

1.3

5.64

5.71

mmol/l

0.39

211

1518

Oedema, not elsewhere classified

721

1.23

1.17

1.3

5.76

5.81

mmol/l

0.12

689

Macular pucker

298

0.64

1.17

1.2

5.62

6.23

mmol/l

3.18

274

Chronic mastoiditis

0.00

1.16

0.0

1.3

—

6.56

—

Diarrhoea and gastroenteritis of presumed infectious origin

235

1845

1.14

1.16

1.3

1.4

5.68

5.54

mmol/l

0.71

218

1757

Other viral diseases, not elsewhere classified, including avohilmo

771

1.23

1.15

1.4

5.27

5.42

mmol/l

0.91

728

Other disorders of choroid

2.51

1.15

1.0

1.3

5.68

7.06

mmol/l

—

Erectile dysfunction

110

1.64

1.15

1.2

6.18

6.37

mmol/l

0.30

104

Raynaud syndrome

222

0.58

1.13

1.5

1.4

4.96

5.58

mmol/l

2.86

211

Diseases of arteries, arterioles and capillaries (FINNGEN)

271

1.32

1.12

1.3

1.2

6.30

5.96

mmol/l

0.90

260

Unspecified privation

221

0.59

1.12

1.6

1.4

5.10

5.77

mmol/l

3.10

211

Injury of muscle and tendon at shoulder and upper arm level

673

1.23

1.09

1.3

5.99

6.06

mmol/l

0.28

633

Synovial hypertrophy, not elsewhere classified

2.40

1.09

1.0

1.4

5.30

6.73

mmol/l

—

Assault by other specified means

2.40

1.09

1.2

1.3

5.92

6.46

mmol/l

—

Benign neoplasm: Connective and other soft tissue, unspecified

2.40

1.09

1.2

1.1

5.71

6.84

mmol/l

—

Heart failure, not strict

187

1091

1.15

1.09

1.2

1.3

6.26

5.92

mmol/l

2.21

168

1027

Streptococcal septicaemia

162

0.55

1.08

1.2

1.3

6.77

5.99

mmol/l

—

153

Other specified/unspecified spondylopathies

2.20

1.08

1.0

1.3

5.33

6.62

mmol/l

—

Other disorders of eyelid

109

858

1.20

1.08

1.4

1.3

5.93

5.94

mmol/l

0.01

100

805

All anxiety disorders

238

1635

1.13

1.07

1.5

1.4

5.64

5.43

mmol/l

1.30

230

1547

Cough

119

937

1.19

1.05

1.3

1.4

5.72

5.66

mmol/l

0.34

110

894

Abrasion of teeth

117

988

1.19

1.03

1.3

1.4

5.78

5.71

mmol/l

0.12

104

934

Conjunctivitis

221

2007

0.89

1.03

1.5

1.4

5.46

5.52

mmol/l

0.35

208

1902

Diseases of middle ear and mastoid

213

1534

1.13

1.03

1.4

5.23

5.44

mmol/l

2.26

201

1454

Postprocedural disorders of nervous system

203

0.59

1.03

1.5

4.78

5.38

mmol/l

2.62

197

Papulosquamous disorders

113

952

1.19

1.03

1.3

5.76

5.81

mmol/l

0.21

106

896

Other puerperal infections

341

1.32

1.03

1.8

1.6

4.90

5.11

mmol/l

1.27

326

Diseases of the skin and subcutaneous tissue

342

1550

1.11

1.02

1.4

5.58

5.59

mmol/l

0.07

323

1469

Visual disturbances

149

1286

1.16

1.01

1.4

5.61

5.67

mmol/l

0.18

144

1213

Any gastric operation

303

1365

1.11

1.01

1.4

5.65

5.42

mmol/l

1.37

287

1299

GASTRO-related operations

303

1365

1.11

1.01

1.4

5.65

5.42

mmol/l

1.37

287

1299

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

155

1.49

1.01

1.3

1.4

5.96

5.83

mmol/l

0.18

146

Diagnoses used for exclusion with ILD

484

0.74

1.00

1.2

1.3

5.94

5.98

mmol/l

0.06

461

Excessive attrition of teeth

217

1904

1.13

1.00

1.3

1.4

5.65

5.52

mmol/l

1.20

205

1805

Hallux rigidus

262

0.65

1.00

1.1

1.2

6.22

6.11

mmol/l

0.21

252

Certain infectious and parasitic diseases, including avohilmo

250

1114

1.12

0.99

1.3

1.4

5.71

5.54

mmol/l

1.53

234

1055

Congenital malformations of the circulatory system

312

0.68

0.99

1.5

1.4

5.23

5.63

mmol/l

1.46

297

Other nonscarring hair loss

2.19

0.98

1.0

1.5

5.38

mmol/l

—

Polyarteritis nodosa and related conditions

2.18

0.98

1.4

1.3

5.24

6.70

mmol/l

—

Burn and corrosion of ankle and foot

2.18

0.98

1.2

5.15

6.84

mmol/l

—

Collagenous colitis

200

0.60

0.98

1.3

1.4

5.51

5.81

mmol/l

0.49

190

Other lack of coordination

2.18

0.98

2.0

1.1

6.20

6.97

mmol/l

—

Implicit Sepsis, including avohilmo

246

1568

1.12

0.98

1.2

1.4

5.86

5.71

mmol/l

1.26

221

1484

Striking against or struck by other objects

860

0.81

0.98

1.2

1.4

5.76

5.54

mmol/l

0.29

817

Somnolence

0.00

0.97

0.0

1.5

—

6.35

—

Vitamin D deficiency

1.95

0.97

1.7

1.4

5.55

6.02

mmol/l

—

Trochanteric bursitis

301

1.33

0.96

1.2

1.3

5.88

6.02

mmol/l

0.28

282

Tramadol

254

1365

1.12

0.96

1.3

1.4

5.77

5.63

mmol/l

1.30

234

1295

L04AA Selective immunosuppressants

548

0.77

0.96

1.4

5.76

5.71

mmol/l

0.06

517

Mycoses, including avohilmo

309

2132

1.10

0.94

1.3

1.4

5.58

mmol/l

0.05

292

2016

Keratoconus

1.90

0.94

1.4

6.32

6.38

mmol/l

—

Erysipelas, including avohilmo

195

1276

1.13

0.94

1.2

1.3

6.07

5.81

mmol/l

1.81

184

1205

Glucagon-like peptide-1 (GLP-1) analogues

651

1.21

0.93

1.5

1.2

6.97

5.64

mmol/l

4.92

620

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

651

1.21

0.93

1.5

1.2

6.97

5.64

mmol/l

4.92

620

Disorders of breast

191

1487

1.13

0.92

1.4

5.42

5.45

mmol/l

0.15

179

1408

Congenital malformations of heart and great arteries

259

0.67

0.90

1.3

1.4

5.38

5.65

mmol/l

0.49

247

Other and unspecified disorders of vitreous body

107

891

1.17

0.89

1.3

5.90

6.04

mmol/l

0.92

832

Benign lipomatous neoplasm of other sites/unspecified

135

1.48

0.89

1.1

1.3

6.24

6.08

mmol/l

0.29

128

Coxarthrosis [arthrosis of hip](FG)

129

765

1.16

0.88

1.2

6.01

6.09

mmol/l

0.44

118

725

Fentanyl

154

0.58

0.88

1.2

6.40

6.18

mmol/l

—

148

Malignant neoplasm of ovary, including Hilmo

128

0.55

0.88

1.4

1.3

5.82

mmol/l

—

121

Second line medication for Crohn's disease

140

1601

0.87

0.88

1.4

5.45

5.69

mmol/l

1.67

129

1509

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

302

2139

1.10

0.87

1.3

1.4

5.64

5.57

mmol/l

0.41

286

2023

Benign neoplasm: Transverse colon

205

0.63

0.87

1.5

1.3

5.92

6.10

mmol/l

0.28

191

Selective serotonin reuptake inhibitors

334

1584

1.10

0.87

1.4

5.86

5.52

mmol/l

3.96

312

1512

Stroke, excluding SAH

127

791

1.16

0.86

1.3

6.08

6.07

mmol/l

0.03

119

746

Nonsuppurative otitis media, including avohilmo

129

966

1.16

0.86

1.5

5.18

5.26

mmol/l

0.36

120

924

Hyperaldosteronism

1.82

0.86

1.3

5.97

6.38

mmol/l

—

MS-disease / Multiple Sclerosis

192

0.62

0.85

1.3

1.5

5.61

5.48

mmol/l

0.14

185

Visual disturbances and blindness

154

1352

1.14

0.85

1.4

5.68

mmol/l

0.01

148

1273

Unstable angina pectoris

466

1.21

0.84

1.2

6.21

6.19

mmol/l

0.04

445

Myocardial infarction, strict

542

1.19

0.84

1.2

6.08

6.19

mmol/l

0.50

519

Implicit Sepsis

212

1398

1.12

0.84

1.3

1.4

5.92

5.76

mmol/l

1.22

193

1321

Hepatic failure, not elsewhere classified

1.76

0.83

1.1

1.3

6.15

6.29

mmol/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

238

1667

1.11

0.83

1.4

5.40

5.47

mmol/l

0.59

228

1578

Lesion of ulnar nerve

274

1.32

0.83

1.3

5.58

5.87

mmol/l

1.09

267

Artificial joint re-operation

111

0.54

0.83

1.2

1.3

5.56

6.17

mmol/l

—

105

Other fall from one level to another

551

1.22

0.83

1.3

1.4

5.57

5.56

mmol/l

0.01

523

Fall on same level involving ice and snow

176

1564

1.13

0.82

1.2

1.4

5.81

5.68

mmol/l

0.90

167

1475

Behavioural syndromes associated with physiological disturbances and physical factors

317

1962

1.09

0.82

1.3

1.4

5.55

5.58

mmol/l

0.21

298

1857

Other specific arthropathies, wide

1.88

0.82

1.0

1.3

5.48

6.49

mmol/l

—

Peritonsillar abscess

607

1.20

0.82

1.2

1.5

5.60

5.40

mmol/l

0.28

580

Symptoms and signs involving cognition, perception, emotional state and behaviour

312

1906

1.09

0.81

1.3

1.4

5.72

5.62

mmol/l

0.84

284

1813

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

142

1582

0.88

0.81

1.3

1.4

5.92

5.71

mmol/l

0.83

133

1491

Polyp of the female genital tract

528

0.84

0.81

1.3

1.4

5.76

5.44

mmol/l

2.86

506

Coxarthrosis

119

663

1.16

0.81

1.2

6.02

6.05

mmol/l

0.15

109

630

Benign paroxysmal vertigo

644

1.20

0.81

1.4

1.3

5.78

5.91

mmol/l

0.65

605

Reimbursement for rheumatic diseases

133

1507

0.88

0.80

1.3

1.4

5.50

5.73

mmol/l

1.63

124

1418

Sleep disorders

308

1941

1.09

0.80

1.3

1.4

5.55

5.58

mmol/l

0.14

292

1838

Other protozoal intestinal diseases

0.00

0.79

0.0

1.5

—

6.22

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

0.00

0.79

0.0

1.2

—

6.95

—

Benign neoplasm: Skin of upper limb, including shoulder

1.82

0.79

2.0

1.4

5.33

6.46

mmol/l

—

Certain zoonotic bacterial diseases, including avohilmo

1.67

0.79

1.0

1.3

5.64

6.21

mmol/l

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.00

0.78

0.0

1.2

—

6.73

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

0.00

0.78

0.0

1.2

—

6.73

—

Use of levodopa decarboxylase inhibitor

223

0.67

0.78

1.2

6.01

6.19

mmol/l

0.34

208

Inflammatory diseases of the central nervous system

163

0.61

0.78

1.1

1.4

5.54

5.86

mmol/l

—

155

Other peripheral vascular diseases

175

0.63

0.78

1.6

1.4

5.33

5.78

mmol/l

0.89

167

Cervicalgia

474

1.22

0.78

1.3

5.66

5.78

mmol/l

0.42

448

Polyarthropathies

206

1190

1.11

0.76

1.3

1.4

5.69

5.62

mmol/l

0.36

188

1134

Disorders of conjunctiva

243

2067

0.91

0.76

1.5

1.4

5.48

5.55

mmol/l

0.42

229

1959

Viral encephalitis, not elsewhere classified/unspecified

0.00

0.76

0.0

1.4

—

6.66

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

0.00

0.76

0.0

1.4

—

6.66

—

Ischaemic Stroke, excluding all haemorrhages

116

742

1.15

0.75

1.3

1.2

6.06

6.09

mmol/l

0.09

107

699

Injuries to the head

328

2109

0.92

0.75

1.3

1.4

5.62

5.58

mmol/l

0.28

304

2000

Injuries to the ankle and foot

253

1970

1.10

0.75

1.4

5.40

5.54

mmol/l

1.25

240

1867

Haemorrhage from respiratory passages

551

1.19

0.74

1.3

6.05

5.91

mmol/l

0.43

527

Condition for Implicit Sepsis (Organ dysfunction codes)

256

1617

1.10

0.74

1.3

1.4

5.88

5.70

mmol/l

1.79

231

1533

Codeine

332

1653

1.09

0.73

1.4

5.71

5.48

mmol/l

2.80

308

1570

Benign neoplasm: Skin of ear and external auricular canal

1.64

0.73

1.6

1.4

6.11

6.23

mmol/l

—

Necrosis of pulp, including avohilmo

197

1757

1.11

0.73

1.4

5.65

5.58

mmol/l

0.25

184

1666

Deep bite that required surgery

2.01

0.73

1.2

1.5

5.62

6.33

mmol/l

—

Toxic effect of other and unspecified substances

2.01

0.73

1.6

1.4

5.26

6.35

mmol/l

—

Drug-induced adrenocortical insufficiency

2.01

0.73

1.2

5.66

6.89

mmol/l

—

Family history of other conditions

1.80

0.72

1.1

1.5

6.04

5.88

mmol/l

—

Amputation of toe

106

0.57

0.72

1.2

6.02

6.29

mmol/l

—

101

Complications of procedures, not elsewhere classified

258

1900

1.09

0.72

1.3

1.4

5.70

5.64

mmol/l

0.28

245

1793

Implicit bacterial Sepsis, including avohilmo

103

742

1.15

0.72

1.2

1.3

6.02

5.96

mmol/l

0.20

703

Hyperprolactinaemia

1.53

0.72

1.4

1.5

5.53

5.59

mmol/l

0.06

Benign neoplasm: Adrenal gland

142

1.41

0.72

1.1

1.3

6.29

6.13

mmol/l

0.14

136

Other congenital malformations of ear

1.76

0.71

2.0

1.6

5.06

mmol/l

—

Insomnia

306

1961

1.09

0.71

1.3

1.4

5.52

5.57

mmol/l

0.29

292

1858

Missing teeth due to accident, extraction or parodontitis

158

1260

1.12

0.71

1.2

1.3

6.07

5.89

mmol/l

0.98

145

1184

Retinal vascular occlusion

194

1.34

0.71

1.4

1.3

6.44

6.15

mmol/l

0.30

182

Retinal vascular disorders

194

1.34

0.71

1.4

1.3

6.45

6.15

mmol/l

0.30

182

Other specified and unspecified personality disorders

238

1.30

0.70

1.2

1.5

5.71

5.47

mmol/l

0.68

229

Heart failure and coronary heart disease

476

1.18

0.70

1.2

6.16

6.19

mmol/l

0.08

455

Stroke, including SAH

136

863

1.13

0.70

1.3

1.2

6.06

mmol/l

0.03

128

815

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

139

0.63

0.69

1.8

1.6

4.77

5.16

mmol/l

—

134

Other disorders of fluid, electrolyte and acid-base balance

513

1.19

0.69

1.2

1.3

6.43

6.00

mmol/l

1.25

484

Other chronic obstructive pulmonary disease

627

1.16

0.68

1.3

1.2

6.26

6.11

mmol/l

0.25

588

Amputation of ankle bones

1.86

0.68

1.0

1.1

8.14

6.91

mmol/l

—

Solid cancers

209

1348

0.91

0.68

1.2

1.3

5.91

5.74

mmol/l

1.45

199

1267

Fracture of forearm

141

1419

0.89

0.68

1.3

1.4

5.60

5.67

mmol/l

0.36

134

1340

Malignant neoplasm

216

1389

0.91

0.68

1.2

1.3

5.91

5.72

mmol/l

1.63

206

1305

Other postsurgical states

118

0.59

0.67

1.1

1.4

5.51

6.01

mmol/l

—

111

Myocardial infarction

581

1.15

0.67

1.2

1.3

6.11

6.16

mmol/l

0.18

557

Enteropathic arthropathies

1.63

0.67

1.6

1.3

5.14

5.71

mmol/l

—

Non-small cell lung cancer

154

0.64

0.67

1.3

1.2

6.14

6.30

mmol/l

—

144

Irregular menses

213

1457

1.10

0.66

1.5

1.4

5.45

5.28

mmol/l

1.49

196

1389

Disorders of optic nerve, not elsewhere classified

1.79

0.66

1.4

1.2

6.06

6.77

mmol/l

—

Sensorineural hearing loss

189

1140

1.10

0.66

1.2

1.3

5.90

5.94

mmol/l

0.20

177

1073

Other arthritis (FG)

762

1.16

0.65

1.2

1.3

5.50

5.76

mmol/l

1.90

724

Intestinal infectious diseases

308

2121

1.08

0.65

1.3

1.4

5.64

5.57

mmol/l

0.37

283

2013

Other specified disorders of muscle

1.59

0.65

1.4

1.3

5.65

6.32

mmol/l

—

Inguinal hernia

132

779

1.13

0.65

1.2

1.3

5.85

5.87

mmol/l

0.06

124

736

Sequelae of cerebrovascular disease

534

0.83

0.64

1.3

1.2

6.26

6.13

mmol/l

0.25

503

Donors of organs and tissues

1.73

0.64

1.4

5.52

6.44

mmol/l

—

Acute nephritic syndrome

1.73

0.64

2.2

1.2

5.36

6.61

mmol/l

—

Mycoses

710

0.84

0.63

1.3

1.4

5.57

5.71

mmol/l

0.54

670

Urticaria and erythema

1116

0.88

0.63

1.3

1.4

5.37

5.52

mmol/l

1.04

1054

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

295

1595

1.08

0.63

1.3

1.4

5.76

5.58

mmol/l

1.69

271

1513

295

1595

1.08

0.63

1.3

1.4

5.76

5.58

mmol/l

1.69

271

1513

Alcohol use disorder, ICD-based

102

896

1.14

0.63

1.3

6.00

5.79

mmol/l

0.82

845

Non-follicular lymphoma

155

1.36

0.63

1.4

1.3

5.99

6.14

mmol/l

0.26

148

Malignant neoplasm

217

1388

0.91

0.62

1.2

1.3

5.91

5.73

mmol/l

1.59

207

1304

Non-small cell lung cancer, adenocarcinoma, helper endpoint

102

0.59

0.62

1.3

6.35

6.23

mmol/l

—

Carcinoma in situ of skin of upper limb, including shoulder

1.67

0.61

1.2

5.95

6.86

mmol/l

—

Colonic or urogenital fistula

618

1.17

0.61

1.5

1.3

5.78

mmol/l

0.02

588

Malignant neoplasm of skin

740

0.88

0.61

1.2

1.3

6.11

6.00

mmol/l

0.39

690

Injuries to the elbow and forearm

196

1835

0.91

0.60

1.3

1.4

5.62

5.60

mmol/l

0.08

186

1734

Infection due to other mycobacteria

0.00

0.60

0.0

1.3

—

7.13

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

0.00

0.60

0.0

1.2

—

5.85

—

Lifestyle-related condition

0.00

0.60

0.0

1.3

—

6.70

—

Carcinoma in situ of rectum

0.00

0.60

0.0

1.2

—

6.97

—

Abscess of lung

0.00

0.60

0.0

1.1

—

7.10

—

Other and unspecified haemorrhagic conditions

0.00

0.60

0.0

1.2

—

6.90

—

Infection due to other mycobacteria, including avohilmo

0.00

0.60

0.0

1.3

—

7.01

—

Other anxiety disorders

180

1394

1.10

0.60

1.5

1.4

5.61

5.35

mmol/l

1.34

175

1322

Diseases of the myoneural junction and muscle

227

1.28

0.59

1.2

1.3

6.04

5.93

mmol/l

0.15

215

Superficial injury of thorax

344

1.22

0.59

1.5

1.4

5.76

5.71

mmol/l

0.09

326

Iliotibial band syndrome

0.00

0.59

0.0

1.5

—

5.80

—

Other factor of the environment

0.00

0.59

0.0

1.3

—

6.73

—

Hereditary retinal dystrophy

0.00

0.59

0.0

1.4

—

6.69

—

Malignant neoplasm of other and unspecified parts of tongue

0.00

0.59

0.0

1.2

—

7.01

—

Other degenerative diseases of the basal ganglia

0.00

0.59

0.0

1.2

—

7.24

—

Other noninfective gastroenteritis and colitis

585

0.84

0.59

1.3

1.4

5.49

5.68

mmol/l

0.58

555

Other heart diseases, wide

308

1734

1.07

0.59

1.3

1.4

5.71

5.56

mmol/l

1.53

292

1648

Other coagulation defects

174

0.69

0.59

1.4

5.42

5.62

mmol/l

0.28

168

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

0.00

0.58

0.0

1.3

—

6.58

—

Carcinoma in situ of breast, other/unspecified

0.00

0.58

0.0

1.2

—

5.67

—

Scleritis

0.00

0.58

0.0

1.2

—

6.67

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

216

1461

1.09

0.58

1.4

5.35

mmol/l

0.03

208

1382

Failed attempted abortion

1.72

0.58

1.3

1.4

4.82

5.10

mmol/l

—

Infective bursitis

1.72

0.57

1.3

1.1

5.55

6.75

mmol/l

—

Viral and other specified intestinal infections, including avohilmo

902

0.87

0.57

1.3

1.5

5.29

5.22

mmol/l

0.20

867

Anxiety disorders

305

1950

1.07

0.57

1.4

5.73

5.55

mmol/l

1.33

287

1843

Complications of medical and surgical care

191

1869

0.92

0.56

1.3

5.87

5.66

mmol/l

1.10

180

1761

Benign neoplasm of ovary

397

0.81

0.56

1.3

5.43

5.73

mmol/l

1.44

371

Other and unspecified effects of external causes

811

1.14

0.56

1.3

1.4

5.47

5.46

mmol/l

0.03

766

Dyspnoea

277

1859

1.07

0.56

1.3

5.82

5.65

mmol/l

1.88

254

1764

Other diseases of pleura

720

0.87

0.56

1.3

1.2

6.16

6.07

mmol/l

0.28

677

Codeine or tramadol medication

379

1933

1.06

0.56

1.4

5.76

5.54

mmol/l

3.01

352

1835

Mental and behavioural disorders due to alcohol, excluding acute intoxication

108

954

1.12

0.55

1.3

6.01

5.80

mmol/l

0.92

103

900

Disorders of globe

1.63

0.55

1.2

1.4

7.35

6.51

mmol/l

—

Presence of other functional implants

107

822

0.89

0.55

1.2

1.3

6.03

6.05

mmol/l

0.05

771

Genitourinary diseases

160

728

1.10

0.55

1.3

1.4

5.56

5.54

mmol/l

0.08

154

698

Conductive and sensorineural hearing loss

203

1239

1.09

0.54

1.2

1.3

5.88

5.89

mmol/l

0.05

189

1165

Bronchiectasis

124

0.64

0.54

1.5

1.3

6.00

5.99

mmol/l

—

117

Dermatitis due to substances taken internally

125

0.64

0.54

1.1

1.5

5.16

5.76

mmol/l

—

119

Benign neoplasm: Anus and anal canal

1.58

0.54

1.0

1.2

5.42

6.51

mmol/l

—

Viral and other specified intestinal infections

639

0.85

0.54

1.4

1.5

5.29

5.21

mmol/l

0.16

615

Restless leg syndrome

312

1.22

0.54

1.3

1.4

5.44

5.77

mmol/l

1.44

299

Keratitis

105

937

1.12

0.54

1.3

1.4

5.60

5.68

mmol/l

0.25

886

Nonalcoholic fatty liver disease

204

1.28

0.54

1.4

1.3

5.67

5.87

mmol/l

0.46

195

Benign neoplasm: Skin of eyelid, including canthus

294

1.23

0.54

1.3

5.49

5.98

mmol/l

2.13

279

ILD medications: immunosuppressive drugs

173

1708

0.92

0.53

1.4

5.53

5.62

mmol/l

0.40

160

1618

Anomalies of pupillary function

1.54

0.53

1.7

1.4

5.78

5.68

mmol/l

—

Erythema intertrigo

1.54

0.53

1.2

1.3

5.15

6.48

mmol/l

—

Disorders of vitreous body and globe

129

1102

1.11

0.53

1.3

6.00

5.97

mmol/l

0.08

119

1034

Injuries to the wrist and hand

337

2097

1.06

0.53

1.3

1.4

5.63

5.57

mmol/l

0.41

321

1981

Acute appendicitis, no complications

180

1644

1.09

0.52

1.5

1.4

5.41

5.60

mmol/l

1.60

169

1561

Coagulation defects, purpura and other haemorrhagic conditions

469

0.83

0.52

1.5

1.4

5.49

5.67

mmol/l

0.72

443

Melanocytic naevi

929

0.88

0.52

1.4

5.48

5.56

mmol/l

0.24

878

Inflammatory bowel disease treatment related agents

379

1980

1.06

0.52

1.3

1.4

5.68

5.56

mmol/l

1.04

353

1881

Heart failure,strict

107

667

1.12

0.52

1.2

1.3

6.25

6.09

mmol/l

0.78

629

Non-small cell lung cancer, adenocarcinoma

0.61

0.52

1.3

6.35

6.24

mmol/l

—

Unspecified abortion

100

1.40

0.51

1.3

5.83

5.50

mmol/l

0.71

Other or unspecified ileus, impaction or obstruction

326

0.80

0.51

1.3

1.2

6.31

6.09

mmol/l

0.38

306

Use of galantamine

100

1.40

0.51

1.2

6.42

6.37

mmol/l

0.04

Obsessive-compulsive disorder

248

0.76

0.51

1.3

1.6

5.46

5.13

mmol/l

0.71

241

Temporomandibular joint disorders, including avohilmo

178

1585

1.09

0.51

1.4

5.24

5.39

mmol/l

1.66

167

1509

Other viral diseases, including avohilmo

133

1195

1.10

0.51

1.4

5.35

5.38

mmol/l

0.10

124

1137

Coeliac disease

287

1.22

0.51

1.4

5.67

5.61

mmol/l

0.14

273

Malignant neoplasm, including Hilmo

234

1466

0.93

0.51

1.3

5.86

5.69

mmol/l

1.56

223

1379

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

109

1.38

0.51

1.3

1.4

5.87

5.95

mmol/l

0.08

102

Disorders of sclera, cornea, iris and ciliary body

160

1466

1.09

0.51

1.3

1.4

5.67

mmol/l

0.01

147

1392

Malignant neoplasm of breast, ER-positive, including Hilmo

627

0.88

0.50

1.2

1.3

5.89

5.80

mmol/l

0.31

588

Other bursopathies

242

1.24

0.50

1.4

1.3

5.74

6.05

mmol/l

0.92

229

ILD, hospital admissions 3, with pneumonia sepsis

145

0.69

0.50

1.4

1.3

6.32

6.18

mmol/l

—

136

Other antidepressants

330

1582

1.06

0.50

1.3

1.4

5.90

5.52

mmol/l

4.16

308

1511

Other renal tubulo-interstitial diseases

1.47

0.50

1.5

1.3

5.80

5.82

mmol/l

—

Coxarthrosis, primary, with hip surgery

794

1.12

0.50

1.2

1.3

6.02

6.15

mmol/l

0.75

744

Coronary artery bypass grafting

253

1.20

0.50

1.2

6.46

6.28

mmol/l

0.32

243

Left bundle-branch block

118

1.36

0.50

1.3

5.89

6.20

mmol/l

0.70

108

Pain, not elsewhere classified

763

1.13

0.50

1.3

1.4

5.68

5.60

mmol/l

0.32

727

Oter anti-inflammatory and antirheumatic agents, non-steroids

197

1.20

0.49

1.3

5.89

5.95

mmol/l

0.15

187

L04AX Other immunosuppressants

140

1532

0.91

0.49

1.4

5.45

5.70

mmol/l

1.85

129

1446

Melanocytic naevi, other sites/unspecified

198

1.26

0.49

1.4

5.47

5.68

mmol/l

0.42

191

Venous thromboembolism

105

1123

0.90

0.49

1.3

5.78

5.91

mmol/l

0.69

1057

Malignant neoplasm of breast, HER-positive

626

0.88

0.49

1.2

1.3

5.89

5.80

mmol/l

0.30

587

Acute tubulo-interstitial nephritis

167

1531

0.92

0.49

1.3

1.4

5.91

5.56

mmol/l

1.94

158

1443

Venous complications and haemorrhoids in pregnancy

1.56

0.49

1.4

5.20

5.01

mmol/l

—

Other disorders of iris and ciliary body

1.56

0.49

1.1

1.3

5.16

6.32

mmol/l

—

Cystic kidney disease

1.56

0.49

1.6

1.4

5.59

6.15

mmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

283

1675

1.07

0.48

1.3

5.77

5.75

mmol/l

0.14

268

1577

Renal tubulo-interstitial diseases

242

1898

0.93

0.48

1.3

1.4

6.03

5.57

mmol/l

3.45

228

1794

Benign neoplasms

337

1727

1.06

0.48

1.4

5.56

5.50

mmol/l

0.40

320

1631

Malignant neoplasm, wide definition

234

1461

0.93

0.48

1.3

5.86

5.69

mmol/l

1.53

223

1375

Volvulus

1.52

0.48

1.0

1.4

7.16

6.37

mmol/l

—

Cervicocranial syndrome

226

1.24

0.48

1.4

5.69

5.70

mmol/l

0.02

219

Complications of genitourinary prosthetic devices, implants and grafts

1.49

0.47

1.1

1.5

5.48

6.30

mmol/l

—

Neurotic, stress-related and somatoform disorders

300

1943

1.06

0.47

1.4

5.73

5.54

mmol/l

1.37

283

1835

Superficial injuries involving multiple body regions

1.46

0.47

1.1

1.4

6.94

6.14

mmol/l

—

COPD, hospital admissions

677

1.12

0.46

1.3

1.2

6.25

6.10

mmol/l

0.24

636

Urticaria

940

0.89

0.46

1.3

1.4

5.36

5.51

mmol/l

0.79

891

Female infertility

114

754

0.91

0.46

1.6

1.5

5.34

5.17

mmol/l

0.43

106

727

Vascular diseases of the intestine

1.43

0.46

1.3

1.2

6.66

6.29

mmol/l

—

Acute generalized exanthematous pustulosis

0.61

0.45

1.0

1.4

5.40

5.89

mmol/l

—

Orchitis and epididymitis

117

0.68

0.45

1.3

1.2

5.90

6.52

mmol/l

—

109

Glaucoma-related operations

0.59

0.45

1.0

1.2

6.18

6.22

mmol/l

—

Coxarthrosis, primary

128

969

1.10

0.45

1.2

6.07

6.08

mmol/l

0.08

116

909

COPD

654

1.12

0.45

1.4

1.2

6.25

6.09

mmol/l

0.26

615

Benign neoplasm: Other and unspecified parts of mouth

1.40

0.45

1.6

1.4

5.60

6.34

mmol/l

—

Complications of surgical and medical care, not elsewhere classified

314

1976

1.06

0.45

1.3

1.4

5.70

5.62

mmol/l

0.52

298

1865

Disorders of vitreous body

125

1085

1.10

0.45

1.3

6.02

5.98

mmol/l

0.16

115

1018

410

1.15

0.44

1.3

1.2

6.12

6.22

mmol/l

0.25

382

137

1296

0.92

0.43

1.3

1.4

5.92

5.70

mmol/l

1.34

130

1228

Social phobias

285

0.81

0.43

1.5

5.66

5.14

mmol/l

2.27

273

Other disorders starting during childhood or adolescence

126

0.71

0.43

1.8

1.5

4.77

5.19

mmol/l

—

121

Atrophic disorders of skin

386

1.17

0.43

1.3

5.58

5.74

mmol/l

0.47

363

Open wound of shoulder and upper arm

1.62

0.43

1.0

1.5

5.76

6.40

mmol/l

—

Paraplegia, diplegia of upper limbs

1.62

0.43

1.6

1.2

5.29

6.66

mmol/l

—

Other bacterial intestinal infections, including avohilmo

536

1.14

0.43

1.2

1.4

6.05

5.74

mmol/l

0.43

515

ILD, hospital admission 2, with pulmonary infections

151

0.73

0.42

1.4

1.3

6.27

6.13

mmol/l

0.13

141

Fracture of rib(s), sternum and thoracic spine

607

0.87

0.42

1.2

1.3

6.58

5.92

mmol/l

0.78

576

Noninfective enteritis and colitis

114

1246

0.91

0.42

1.4

5.51

5.63

mmol/l

0.64

1181

Prominent ears

1.57

0.42

2.2

1.5

5.10

5.01

mmol/l

—

Other reaction to severe stress, and adjustment disorders

114

1246

0.91

0.42

1.4

5.58

5.35

mmol/l

1.64

108

1187

Disorders of eyelid, lacrimal system and orbit

265

1829

1.06

0.41

1.3

1.4

5.75

5.66

mmol/l

0.41

251

1729

Whooping cough

0.00

0.41

0.0

1.5

—

6.93

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.41

0.0

1.2

—

7.17

—

Myotonic disorders

0.00

0.41

0.0

1.1

—

7.20

—

Neoplasms

283

1400

1.06

0.41

1.4

5.38

5.41

mmol/l

0.21

267

1328

Atypical virus infections of central nervous system

0.00

0.41

0.0

1.1

—

7.42

—

Folate deficiency anaemia

0.00

0.41

0.0

1.1

—

7.63

—

Exfoliative dermatitis

0.00

0.41

0.0

1.2

—

7.44

—

Measles, including avohilmo

0.00

0.41

0.0

1.3

—

5.88

—

Early syphilis

0.00

0.41

0.0

1.3

—

7.46

—

Hyperosmolality and hypernatraemia

0.00

0.41

0.0

1.3

—

7.82

—

Visual field defects

150

0.73

0.41

1.1

1.3

5.70

6.00

mmol/l

0.51

143

Respiratory tuberculosis, confirmed

0.00

0.41

0.0

1.2

—

7.72

—

Congenital obstruction of the pelviureteric junction

0.00

0.41

0.0

1.1

—

5.95

—

Atypical virus infections of central nervous system, including avohilmo

0.00

0.41

0.0

1.1

—

7.35

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

0.00

0.41

0.0

1.2

—

7.43

—

Other nonthrombocytopenic purpura

0.00

0.41

0.0

1.4

—

7.30

—

Exposure to unspecified smoke, fire and flames

0.00

0.41

0.0

1.3

—

7.37

—

Haemorrhagic disorder due to circulating anticoagulants

0.00

0.41

0.0

1.1

—

7.77

—

Respiratory tuberculosis, confirmed, including avohilmo

0.00

0.41

0.0

1.2

—

7.64

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

0.00

0.41

0.0

1.2

—

7.59

—

Oxicams

288

1.14

0.41

1.2

1.4

5.86

5.58

mmol/l

1.11

272

1.36

0.41

1.9

1.5

5.16

4.96

mmol/l

—

Acquired stenosis of external ear canal

0.00

0.40

0.0

1.2

—

7.30

—

Mesial bite

0.00

0.40

0.0

1.5

—

6.47

—

Severe visual impairment, monocular

0.00

0.40

0.0

1.2

—

7.30

—

Diseases caused by chlamydiae

0.00

0.40

0.0

1.3

—

5.65

—

Exposure to excessive natural cold

0.00

0.40

0.0

1.2

—

7.29

—

Other diseases caused by chlamydiae

0.00

0.40

0.0

1.3

—

5.65

—

Other autoimmune haemolytic anaemias

0.00

0.40

0.0

1.1

—

7.44

—

Malignant neoplasm of anus and anal canal, including Hilmo

0.00

0.40

0.0

1.2

—

7.27

—

Benign neoplasm: Bronchus and lung

0.00

0.40

0.0

1.2

—

7.37

—

Other and unspecified injuries of neck

0.00

0.40

0.0

1.4

—

5.76

—

Other and unspecified immunodeficiencies with predominantly antibody defects

0.00

0.40

0.0

1.1

—

7.05

—

Spondylopathies in diseases classified elsewhere

0.00

0.40

0.0

1.1

—

7.22

—

COPD related to multimorbidity

567

1.12

0.40

1.3

1.2

6.40

6.13

mmol/l

0.41

530

Early syphilis, including avohilmo

0.00

0.40

0.0

1.3

—

7.09

—

Implicit bacterial Sepsis

673

1.11

0.40

1.2

1.3

6.10

6.00

mmol/l

0.34

636

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

0.00

0.40

0.0

1.2

—

7.06

—

Other extrapyramidal and movement disorders in other diseases

568

1.13

0.40

1.2

1.3

5.68

5.85

mmol/l

0.79

535

Candidiasis, including avohilmo

961

0.90

0.40

1.3

1.4

5.52

5.47

mmol/l

0.16

907

COPD, early/later onset

683

1.11

0.39

1.3

1.2

6.25

6.10

mmol/l

0.25

640

Other bacterial diseases

265

1656

1.06

0.39

1.2

1.4

6.03

5.71

mmol/l

3.37

249

1558

Autoimmune diseases

368

1777

1.05

0.39

1.4

5.73

5.53

mmol/l

1.35

344

1692

Mumps

1.43

0.39

1.4

1.3

6.32

6.38

mmol/l

—

Hypogonadotropic hypogonadism

1.43

0.39

1.4

1.3

5.87

6.70

mmol/l

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

0.00

0.39

0.0

1.4

—

6.77

—

Acute poliomyelitis

0.00

0.39

0.0

1.1

—

7.20

—

Acute poliomyelitis, including avohilmo

0.00

0.39

0.0

1.1

—

7.20

—

Universal erythroderma, KELA reimbursement

0.00

0.39

0.0

1.2

—

7.10

—

Suppurative and unspecified otitis media

132

1079

1.08

0.38

1.4

1.5

5.26

5.28

mmol/l

0.07

127

1031

Gonarthrosis, primary, with knee surgery

122

873

1.09

0.38

1.3

1.2

5.96

6.11

mmol/l

1.17

111

824

Appendicitis, broad definition

234

1979

1.06

0.38

1.4

5.48

5.60

mmol/l

1.06

220

1874

Mumps, including avohilmo

1.39

0.38

1.4

1.3

6.32

6.37

mmol/l

—

Other diseases of lip and oral mucosa

120

1105

1.09

0.38

1.3

1.4

5.72

mmol/l

0.00

113

1046

Depression or dysthymia

204

1044

1.07

0.38

1.4

5.77

5.56

mmol/l

1.87

190

988

Anxiety disorders, excluding more controls

271

1638

1.06

0.38

1.4

5.77

5.52

mmol/l

2.06

254

1549

Diseases of the eye and adnexa

294

1396

1.06

0.37

1.4

5.57

5.44

mmol/l

0.59

280

1322

Female infertility, tubal origin

147

0.75

0.37

1.2

1.6

6.39

5.31

mmol/l

0.80

142

Other necrotizing vasculopathies

116

1.29

0.37

1.1

1.3

5.70

6.11

mmol/l

0.82

110

Concussion

158

1141

1.07

0.37

1.4

5.63

5.44

mmol/l

1.14

145

1080

Transplanted organ and tissue status

169

0.77

0.37

1.2

1.3

6.61

5.95

mmol/l

0.34

160

Superficial injury of lower leg

705

1.11

0.37

1.3

1.4

5.72

5.62

mmol/l

0.27

667

Bronchitis, not specified as acute or chronic

152

1.25

0.37

1.4

1.3

5.70

5.77

mmol/l

0.14

144

Congenital malformations, deformations and chromosomal abnormalities

177

1789

0.94

0.36

1.5

1.4

5.42

5.47

mmol/l

0.29

171

1697

Allergic asthma (mode), excluding more controls

679

1.11

0.36

1.5

1.4

5.41

5.35

mmol/l

0.23

653

Other and unspecified epidermal thickening

1.43

0.35

1.3

1.5

5.28

6.23

mmol/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

137

1257

1.08

0.35

1.4

5.30

5.39

mmol/l

0.63

130

1197

Nontoxic single thyroid nodule

144

1.25

0.35

1.3

5.79

5.77

mmol/l

0.04

137

Dipeptidyl peptidase 4 (DPP-4) inhibitors

772

0.91

0.35

1.2

7.26

5.80

mmol/l

6.87

732

Other misadventures during surgical and medical care

1.40

0.35

1.3

5.67

6.30

mmol/l

—

Post-traumatic wound infection, not elsewhere classified

1.40

0.35

1.0

1.4

6.12

6.29

mmol/l

—

Fever of other and unknown origin

143

1328

0.93

0.35

1.3

1.4

5.63

5.61

mmol/l

0.08

134

1265

Hydronephrosis

236

1.19

0.34

1.6

1.4

5.51

5.90

mmol/l

1.11

221

Myocardial infarction, without ST-elevation

585

0.89

0.34

1.2

6.11

6.22

mmol/l

0.42

546

ILD medications

377

1944

1.04

0.34

1.4

5.70

5.55

mmol/l

1.40

354

1845

Unspecified chronic bronchitis

1.36

0.34

1.0

1.2

5.69

6.17

mmol/l

—

Diseases of appendix

235

1990

1.06

0.34

1.4

5.48

5.61

mmol/l

1.10

221

1884

Viral warts, including avohilmo

616

0.89

0.34

1.3

1.5

5.76

5.49

mmol/l

0.73

586

Tinnitus

528

1.12

0.34

1.4

1.3

5.62

5.86

mmol/l

1.16

495

Accidents

291

1387

1.05

0.34

1.4

5.68

5.52

mmol/l

0.90

277

1309

Other external causes of accidental injury

291

1387

1.05

0.34

1.4

5.65

5.52

mmol/l

0.74

276

1309

Dermatitis and eczema

361

2045

1.04

0.33

1.4

5.45

5.62

mmol/l

2.16

337

1937

L04AC Interleukin inhibitors

136

1.25

0.33

1.3

1.4

5.62

5.71

mmol/l

0.12

130

Malignant neoplasm of skin, including Hilmo

110

797

0.92

0.33

1.2

1.3

6.09

5.97

mmol/l

0.54

105

742

Abnormal findings on diagnostic imaging of lung

898

0.92

0.32

1.1

1.3

6.30

6.02

mmol/l

0.47

840

Other noninflammatory disorders of vagina

210

1.19

0.32

1.4

1.5

5.27

5.43

mmol/l

0.42

202

Major anomalies of jaw size

1.28

0.32

1.5

4.82

6.18

mmol/l

—

Injuries involving multiple body regions

1.35

0.32

1.2

1.4

6.40

5.89

mmol/l

—

Psoriasis (vulgaris), strict definition

1.28

0.32

1.7

1.4

5.60

6.29

mmol/l

—

Glucosamine medication

698

0.91

0.32

1.3

1.2

5.93

6.12

mmol/l

1.25

654

Other cataract

681

0.92

0.32

1.2

1.3

6.04

6.05

mmol/l

0.03

641

131

1251

0.93

0.31

1.3

1.4

5.93

5.71

mmol/l

1.20

124

1185

Infections of the skin and subcutaneous tissue

172

1595

1.06

0.31

1.5

1.4

5.74

5.60

mmol/l

0.78

167

1502

Other specified/unspecified arthritis

646

1.10

0.31

1.2

1.4

5.48

5.75

mmol/l

1.80

621

Postprocedural disorders of digestive system, not elsewhere classified

1.35

0.31

1.1

1.3

5.70

6.26

mmol/l

—

Infections with a predominantly sexual mode of transmission

101

1087

0.93

0.31

1.3

1.5

5.34

5.30

mmol/l

0.18

1035

Bleeding

189

1400

0.95

0.30

1.3

6.04

5.83

mmol/l

1.36

178

1317

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.71

0.30

1.7

1.2

5.47

6.29

mmol/l

—

L02BB Anti-androgens

131

0.76

0.30

1.1

1.2

6.58

6.41

mmol/l

—

123

Any mental disorder

352

1691

1.04

0.30

1.4

5.86

5.54

mmol/l

3.58

331

1598

Allergic asthma (mode)

688

1.09

0.30

1.5

1.4

5.41

5.36

mmol/l

0.17

662

Diffuse large B-cell lymphoma

1.34

0.30

1.1

1.3

5.63

6.39

mmol/l

—

Diffuse large B-cell lymphoma, including Hilmo

1.34

0.30

1.1

1.3

5.63

6.39

mmol/l

—

Diffuse large B-cell lymphoma, helper endpoint

1.34

0.30

1.1

1.3

5.63

6.39

mmol/l

—

Syncope and collapse

116

902

1.07

0.30

1.3

1.4

5.74

5.73

mmol/l

0.06

105

861

Synovial cyst of popliteal space [Baker]

111

1.26

0.30

1.5

1.3

5.85

6.11

mmol/l

0.31

106

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

672

0.92

0.30

1.2

1.3

6.11

6.07

mmol/l

0.11

624

COPD (mode)

430

1.11

0.30

1.3

1.2

6.40

6.10

mmol/l

0.36

407

Vascular dementia

103

0.75

0.29

1.6

1.1

5.82

6.46

mmol/l

—

Endometriosis ASRM stages 1,2

587

0.90

0.29

1.4

1.5

5.34

5.32

mmol/l

0.05

559

Idiopathic pulmonary fibrosis

110

0.73

0.28

1.3

1.2

6.35

6.27

mmol/l

—

104

Endometriosis of pelvic peritoneum

524

0.90

0.28

1.4

1.5

5.34

5.29

mmol/l

0.18

504

Deep bite

209

0.84

0.28

1.7

1.4

5.66

5.52

mmol/l

0.22

199

Other arrhythmias

192

1360

1.05

0.28

1.2

1.4

5.65

5.70

mmol/l

0.25

178

1288

Certain infectious and parasitic diseases

333

1602

1.04

0.28

1.3

1.4

5.66

5.53

mmol/l

0.97

314

1515

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

428

0.89

0.27

1.2

1.4

5.30

5.61

mmol/l

1.41

406

Heart failure, strict

111

720

1.07

0.27

1.2

1.3

6.24

6.10

mmol/l

0.63

101

676

Other specified/unspecified systemic involvement of connective tissue

118

0.76

0.27

1.2

1.4

5.46

5.87

mmol/l

—

112

Other anaemias

809

0.92

0.27

1.1

1.3

6.27

5.94

mmol/l

0.93

759

Autoimmune diseases related-to ILD

263

2105

1.04

0.26

1.3

1.4

5.54

5.61

mmol/l

0.48

240

1998

Other complications of surgical and medical care, not elsewhere classified

215

1.16

0.26

1.4

1.3

5.43

5.75

mmol/l

0.82

206

Other and unspecified anaemias

800

0.93

0.26

1.1

1.3

6.27

5.95

mmol/l

0.87

750

Appendectomy

208

1890

1.05

0.26

1.4

5.43

5.56

mmol/l

0.87

191

1799

Benign neoplasm: Caecum

192

0.83

0.25

1.1

1.3

5.90

6.15

mmol/l

0.73

181

Disorders of optic nerve and visual pathways

216

1.16

0.25

1.2

1.4

6.28

5.58

mmol/l

0.49

206

Artificial joint operation, meniscal resection

226

1382

1.05

0.25

1.3

5.96

5.91

mmol/l

0.19

209

1305

Malaise and fatigue

142

1057

1.06

0.25

1.3

1.4

5.83

5.67

mmol/l

0.71

132

1004

Sequelae of external causes of morbidity and mortality

589

1.09

0.24

1.3

5.88

5.83

mmol/l

0.09

558

Disorders of other endocrine glands

133

1238

1.06

0.24

1.4

5.87

5.52

mmol/l

1.07

124

1175

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

198

1884

0.96

0.24

1.5

1.4

5.38

5.49

mmol/l

0.87

191

1783

All chronic kidney diseases

131

987

1.06

0.24

1.3

6.04

5.81

mmol/l

0.87

122

929

Infections with a predominantly sexual mode of transmission, including avohilmo

153

1330

1.05

0.24

1.4

1.5

5.21

5.27

mmol/l

0.42

144

1271

Amputation

158

0.82

0.23

1.1

1.3

7.46

6.20

mmol/l

0.64

147

Uterine polyps

472

0.93

0.23

1.3

1.4

5.83

5.51

mmol/l

2.56

450

Polycystic kidney disease

1.32

0.23

1.6

1.4

5.50

6.19

mmol/l

—

Secondary and unspecified malignant neoplasm of lymph nodes

143

1.19

0.23

1.4

1.3

6.16

6.05

mmol/l

0.14

135

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

148

1353

0.95

0.23

1.2

1.3

6.11

5.86

mmol/l

0.71

135

1274

Other inflammation of eyelid, including avohilmo

156

1486

1.05

0.23

1.3

1.4

5.45

5.48

mmol/l

0.12

149

1410

Inguinal of femoral hernia, unilateral

1.28

0.23

1.0

1.3

5.84

6.47

mmol/l

—

Femoral hernia, unilateral

1.28

0.23

1.0

1.3

5.84

6.47

mmol/l

—

Inguinal hernia, unilateral

1.28

0.23

1.0

1.3

5.84

6.47

mmol/l

—

Pain and other conditions associated with female genital organs and menstrual cycle

761

1.07

0.23

1.4

1.5

5.38

5.14

mmol/l

1.64

734

Nail disorders

168

0.83

0.22

1.5

1.4

4.98

5.77

mmol/l

1.99

158

Abnormal findings on examination of blood, without diagnosis

106

904

1.06

0.22

1.3

6.01

5.87

mmol/l

0.47

852

Other orthopaedic follow-up care

0.74

0.22

1.1

1.4

6.37

6.03

mmol/l

—

Lichen simplex chronicus and prurigo

116

1.21

0.22

1.2

1.4

6.07

5.98

mmol/l

0.07

109

Benign neoplasm: Skin of other and unspecified parts of face

199

0.85

0.21

1.3

5.76

5.92

mmol/l

0.22

188

5-aminosalicylic acid

534

0.92

0.21

1.4

5.41

5.57

mmol/l

0.49

505

Yaws, including avohilmo

0.00

0.21

0.0

1.1

—

8.12

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.21

0.0

1.3

—

8.09

—

Malignant neoplasm of oropharynx, including Hilmo

0.00

0.21

0.0

1.2

—

7.88

—

ILD medications: nintedanib

0.00

0.21

0.0

1.2

—

8.13

—

Mandibular prognathia AND surgery (LeFortI or BSSO)

0.00

0.21

0.0

1.2

—

7.74

—

Chloasma

0.00

0.21

0.0

1.1

—

7.66

—

Other and unspecified disorders of binocular movement

0.00

0.21

0.0

1.2

—

7.95

—

Muscle wasting and atrophy, not elsewhere classified

0.00

0.21

0.0

1.3

—

7.94

—

Meckel's diverticulum

0.00

0.21

0.0

1.5

—

7.91

—

Other adrenocortical overactivity

0.00

0.21

0.0

1.4

—

5.76

—

Nail dystrophy

0.00

0.21

0.0

1.3

—

6.08

—

Glaucoma secondary to eye trauma

0.00

0.21

0.0

1.2

—

8.18

—

Other/unspecified crystal arthropathies

0.00

0.21

0.0

1.1

—

8.49

—

Cystic disease of liver

0.00

0.21

0.0

1.0

—

8.00

—

Contact with other specified venomous animals

0.00

0.21

0.0

1.2

—

7.66

—

Disorders of male genital organs in diseases classified elsewhere

0.00

0.21

0.0

1.3

—

8.14

—

Narcolepsy and cataplexy

0.00

0.21

0.0

1.5

—

7.56

—

Leiomyosarcoma

0.00

0.21

0.0

1.2

—

7.85

—

Malignant neoplasm of gallbladder, including Hilmo

0.00

0.21

0.0

1.2

—

8.11

—

Liposarcoma

0.00

0.21

0.0

1.2

—

7.96

—

Impaction of intestines

0.00

0.21

0.0

1.1

—

8.31

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.21

0.0

1.6

—

5.70

—

Cholesteatoma of external ear

0.00

0.21

0.0

1.0

—

8.30

—

Sequelae of poliomyelitis

0.00

0.21

0.0

1.1

—

8.40

—

Malignant neoplasm of retroperitoneum and peritoneum

0.00

0.21

0.0

1.1

—

5.92

—

Unspecified parasitic disease

0.00

0.21

0.0

1.1

—

6.18

—

Meningococcal infection

0.00

0.21

0.0

1.2

—

7.47

—

0.00

0.21

0.0

1.2

—

5.64

—

Unspecified parasitic disease, including avohilmo

0.00

0.21

0.0

1.1

—

6.18

—

Malignant neoplasm of floor of mouth, including Hilmo

0.00

0.21

0.0

1.2

—

7.87

—

Use of entacapone

0.00

0.21

0.0

1.2

—

8.35

—

Malignant neoplasm of parotid gland

0.00

0.21

0.0

1.2

—

8.08

—

Benign neoplasm: Nasopharynx

0.00

0.21

0.0

1.1

—

6.36

—

Hypertension, Pulmonary Arterial

0.00

0.21

0.0

1.2

—

7.60

—

Other congenital malformations of intestine

0.00

0.21

0.0

1.3

—

8.19

—

Benign neoplasm: Rectum/anal canal icd-9

0.00

0.21

0.0

1.2

—

8.01

—

ILD medications: acetylcysteine

0.00

0.21

0.0

1.2

—

8.29

—

Vascular dementia (multiple infarctions)

0.00

0.21

0.0

1.2

—

6.45

—

Type 1 diabetes, wide definition, subgroup 2

0.00

0.21

0.0

1.3

—

5.71

—

Open wound of head

129

1151

1.05

0.21

1.2

1.3

5.68

5.82

mmol/l

0.96

121

1089

Surgical ablation of atrial fibrillation

0.00

0.21

0.0

1.2

—

7.78

—

Mastocytosis

0.00

0.21

0.0

1.1

—

7.92

—

Stenosis and insufficiency of lacrimal passages

182

1.15

0.21

1.3

5.49

5.80

mmol/l

1.13

173

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.21

0.0

1.2

—

7.76

—

Disorders of plasma-protein metabolism, not elsewhere classified

0.00

0.21

0.0

1.2

—

7.63

—

Other and unspecified disorders of pigmentation

0.00

0.21

0.0

1.1

—

7.45

—

Meningococcal infection, including avohilmo

0.00

0.21

0.0

1.2

—

7.44

—

Pyoderma gangrenosum

0.00

0.21

0.0

1.2

—

7.55

—

Bullous keratopathy

0.00

0.21

0.0

1.2

—

8.18

—

Exposure to excessive heat of man-made origin

0.00

0.21

0.0

1.1

—

8.07

—

Other bursitis of elbow

0.00

0.21

0.0

1.3

—

7.68

—

Other and unspecified acquired haemolytic anaemias

0.00

0.21

0.0

1.2

—

7.80

—

Torsion of testis

0.00

0.21

0.0

1.2

—

8.03

—

Acute appendicitis

216

1928

1.04

0.21

1.4

5.47

5.61

mmol/l

1.21

204

1828

Nonsuppurative otitis media

700

1.07

0.21

1.5

5.05

5.21

mmol/l

0.90

668

Disorders of skin appendages

153

1592

0.96

0.21

1.3

1.4

5.60

5.49

mmol/l

0.60

145

1508

Idiopathic hypercalciuria

0.00

0.21

0.0

1.2

—

7.64

—

Injury of cranial nerves

0.00

0.21

0.0

1.2

—

7.49

—

Melanoma in situ of lower limb, including hip

0.00

0.21

0.0

1.1

—

7.50

—

Amoebiasis, including avohilmo

0.00

0.21

0.0

1.2

—

7.33

—

Carcinoid syndrome

0.00

0.21

0.0

1.2

—

7.91

—

Malignant neoplasm of gum, including Hilmo

0.00

0.21

0.0

1.2

—

7.66

—

Malignant neoplasm of vulva

0.00

0.21

0.0

1.0

—

5.60

—

Measles

0.00

0.21

0.0

1.3

—

5.87

—

Abdominal aortic aneurysm (AAA)

133

0.82

0.20

1.3

1.2

6.19

6.38

mmol/l

0.22

124

Intracranial injury

153

1490

0.96

0.20

1.4

5.66

5.63

mmol/l

0.14

142

1418

Other diseases of arteries and capillaries

166

0.84

0.20

1.4

1.3

6.63

5.94

mmol/l

0.31

158

Congenital vesicoureteral reflux

0.00

0.20

0.0

1.5

—

5.36

—

Lung transplant status

0.00

0.20

0.0

1.1

—

7.51

—

Lung transplantation

0.00

0.20

0.0

1.1

—

7.51

—

Dacryoadenitis

0.00

0.20

0.0

1.3

—

6.11

—

Corticotropin deficiency

0.00

0.20

0.0

1.1

—

6.26

—

Open wound of neck

0.00

0.20

0.0

1.3

—

7.67

—

Kela reimbursement Agammaglobulinemia (D80-84)

0.00

0.20

0.0

1.1

—

5.81

—

Non-ischemic cardiomyopathy

395

1.08

0.20

1.1

1.3

6.50

6.12

mmol/l

1.20

376

Acute mastoiditis

0.00

0.20

0.0

1.3

—

7.25

—

Liposarcoma, including Hilmo

0.00

0.20

0.0

1.1

—

7.42

—

Atypical mycobacterium lung infection

0.00

0.20

0.0

1.2

—

7.80

—

Extrapyramidal and movement disorders

819

1.06

0.20

1.3

5.77

5.92

mmol/l

0.84

772

Other maltreatment syndromes

1.23

0.20

1.2

1.3

5.85

6.30

mmol/l

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

141

1298

1.05

0.20

1.4

5.65

5.71

mmol/l

0.28

135

1232

Benzodiazepine use

319

2088

1.03

0.19

1.4

5.79

5.56

mmol/l

3.02

299

1978

Falls/tendency to fall

368

1791

1.03

0.19

1.4

5.64

5.52

mmol/l

0.72

351

1694

Acute sinusitis

174

1518

1.04

0.19

1.5

1.4

5.55

5.53

mmol/l

0.07

167

1441

Senile cataract

130

829

0.95

0.19

1.2

1.3

6.16

6.07

mmol/l

0.37

121

781

Medicines for HER+ breast cancer

830

0.94

0.19

1.2

1.3

5.83

5.81

mmol/l

0.08

777

Endometriosis

125

763

0.95

0.19

1.4

1.5

5.35

5.23

mmol/l

0.91

114

733

Disorders of refraction and accommodation

826

0.94

0.19

1.3

1.4

5.49

5.50

mmol/l

0.01

785

All-cause Heart Failure

108

712

1.05

0.19

1.2

1.3

6.25

6.10

mmol/l

0.67

668

Substance abuse

153

1361

1.04

0.19

1.3

1.4

5.88

5.67

mmol/l

1.33

144

1288

Secondary hypertension

116

1.19

0.19

1.1

1.3

6.81

6.03

mmol/l

0.48

111

Congenital malformations of breast

1.16

0.19

1.7

1.6

5.00

5.12

mmol/l

—

L02BG Aromatase inhibitors

667

1.07

0.19

1.1

1.3

5.87

5.83

mmol/l

0.15

622

Solid cancers, including Hilmo

235

1416

0.97

0.19

1.3

5.87

5.71

mmol/l

1.38

224

1333

Oral lichen planus, including avohilmo , including avohilmo

137

1.17

0.18

1.2

1.4

5.75

5.94

mmol/l

0.25

129

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

285

1978

0.97

0.18

1.3

1.4

5.97

5.59

mmol/l

3.28

272

1866

Cerebrovascular diseases

165

1099

1.04

0.18

1.3

6.01

5.98

mmol/l

0.19

155

1032

Follow-up examination after treatment for malignant neoplasms

147

1.16

0.18

1.2

1.3

6.53

6.25

mmol/l

0.33

135

Systemic lupus erythematosus, unspecified

1.17

0.18

1.3

1.4

5.39

5.97

mmol/l

—

Complications following abortion and ectopic and molar pregnancy

1.15

0.17

1.6

1.3

5.61

5.58

mmol/l

—

Neuromuscular dysfunction of bladder

176

1.14

0.17

1.5

1.4

5.85

5.97

mmol/l

0.22

167

Adenocarcinoma and papilloma adenocarcinoma of rectum

157

1.15

0.17

1.1

1.3

5.98

6.22

mmol/l

0.47

148

Female infertility, cervical, vaginal, other or unspecified origin

111

744

0.95

0.17

1.5

5.26

5.18

mmol/l

0.19

105

717

Adrenocortical insufficiency

1.11

0.17

1.1

1.5

7.94

6.02

mmol/l

—

Carcinoma in situ of skin of other and unspecified parts of face

131

0.84

0.17

1.3

1.2

6.15

6.20

mmol/l

0.07

122

Other benign neoplasms of connective and other soft tissue

186

1.13

0.17

1.3

1.4

5.58

5.81

mmol/l

0.49

177

Other and unspecified disorders of skin and subcutaneous tissue

120

0.83

0.16

1.0

1.4

5.11

5.91

mmol/l

—

113

Disorders of parathyroid gland

387

0.92

0.16

1.1

1.3

6.09

5.99

mmol/l

0.12

363

Carbimazole or st.post thyroidectomy, condition for graves disease

563

1.07

0.16

1.5

1.4

5.83

5.65

mmol/l

0.34

533

Erosion of teeth , including avohilmo

846

1.05

0.16

1.3

1.4

5.72

5.40

mmol/l

0.51

803

Asthma and opportunity respiratory infection

1.14

0.16

1.5

1.3

6.00

6.34

mmol/l

—

IBD patients in KELA-register

587

0.94

0.16

1.3

1.4

5.33

5.53

mmol/l

0.80

559

All kidney diseases

300

2061

0.97

0.16

1.3

1.4

5.93

5.53

mmol/l

4.02

281

1954

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1024

0.95

0.15

1.4

1.5

5.47

5.23

mmol/l

1.20

979

First line medication for Crohn's disease

362

1901

1.02

0.15

1.3

1.4

5.72

5.53

mmol/l

1.41

338

1808

Inflammatory bowel disease, strict (require KELA)

586

0.94

0.15

1.3

1.4

5.33

5.54

mmol/l

0.85

556

Aplastic and other anaemias

856

1.05

0.15

1.1

1.3

6.12

5.94

mmol/l

0.46

804

Malignant neoplasm of stomach, including Hilmo

1.08

0.14

1.1

1.2

5.80

6.40

mmol/l

—

Malignant neoplasm of bladder

0.79

0.14

1.1

1.2

5.72

6.38

mmol/l

—

Melanocytic naevi of trunk

316

0.92

0.14

1.5

1.4

5.39

5.62

mmol/l

0.56

301

Transport accidents

151

1299

0.97

0.14

1.4

5.78

5.50

mmol/l

0.90

141

1230

Noninflammatory disorders of female genital tract

158

820

0.97

0.14

1.5

5.24

5.21

mmol/l

0.15

143

789

Disorders of lens

150

962

0.97

0.14

1.2

1.3

6.10

6.00

mmol/l

0.43

140

908

Depression medications

103

540

0.96

0.13

1.4

1.5

5.50

4.96

mmol/l

4.99

518

Acute laryngitis and tracheitis

310

0.92

0.13

1.3

1.5

4.91

5.32

mmol/l

1.81

299

Sulfasalazine

745

0.95

0.13

1.4

5.44

5.69

mmol/l

1.46

703

Vasomotor and allergic rhinitis

123

1160

1.04

0.13

1.5

1.4

5.38

5.46

mmol/l

0.39

118

1105

Asthma and allergy

388

1.07

0.13

1.6

1.5

5.27

5.24

mmol/l

0.07

377

Other and unspecified glaucoma

110

0.82

0.13

1.1

1.2

7.09

6.22

mmol/l

—

103

conjunctival haemorrhage

127

0.87

0.12

1.4

1.3

5.85

6.07

mmol/l

0.36

122

Ulcerative colitis (strict definition, require KELA)

406

0.94

0.12

1.2

1.4

5.30

5.60

mmol/l

1.34

385

LSIL lesion of the cervix uteri, vagina or vulva

502

1.06

0.12

1.3

1.5

5.25

5.22

mmol/l

0.09

481

Ulcerative colitis

610

0.95

0.12

1.3

1.4

5.52

5.61

mmol/l

0.28

580

Other diseases of intestine

282

0.92

0.12

1.3

5.83

6.07

mmol/l

0.54

265

Psychiatric diseases

308

1511

1.02

0.11

1.4

5.85

5.56

mmol/l

4.16

291

1428

Asthma and allergy, excluding more controls

390

1.06

0.11

1.6

1.5

5.27

5.22

mmol/l

0.11

377

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

670

1.04

0.11

1.2

1.3

5.87

5.75

mmol/l

0.46

635

Osteopathies and chondropathies

137

1288

0.97

0.11

1.3

1.4

5.79

5.74

mmol/l

0.23

130

1211

Squamous cell neoplasms and carcinomas of the skin

136

0.88

0.11

1.3

1.2

6.55

6.27

mmol/l

0.38

128

Injuries to the abdomen, lower back, lumbar spine and pelvis

999

0.97

0.10

1.4

5.58

5.70

mmol/l

0.74

944

Inflammatory bowel disease

821

0.96

0.10

1.4

5.50

5.61

mmol/l

0.46

778

Influenza and pneumonia

341

2066

1.02

0.10

1.3

1.4

5.75

5.54

mmol/l

2.54

316

1962

319

0.94

0.10

1.4

1.2

6.12

6.25

mmol/l

0.20

297

Fracture of lower leg, including ankle

139

1401

0.97

0.10

1.4

1.3

5.88

5.74

mmol/l

0.73

128

1322

Adjustment and management of implanted device

251

1.08

0.10

1.1

1.2

5.96

6.17

mmol/l

0.51

236

Dislocation, sprain and strain of joints and ligaments of knee

199

1759

1.02

0.10

1.4

5.58

5.53

mmol/l

0.31

194

1665

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

392

0.94

0.10

1.2

1.4

5.33

5.60

mmol/l

1.11

372

Fibrosis and cirrhosis of liver

135

0.89

0.09

1.0

1.3

6.38

6.13

mmol/l

0.35

129

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

758

0.97

0.09

1.5

1.6

5.20

5.03

mmol/l

0.72

729

Status epilepticus

1.09

0.09

1.0

1.4

5.70

6.30

mmol/l

—

Ovarian cyst

135

793

0.97

0.09

1.4

1.5

5.25

5.22

mmol/l

0.19

130

763

Malignant neoplasm of bladder, including Hilmo

163

0.91

0.09

1.1

1.2

5.79

6.37

mmol/l

1.66

151

Acute renal failure

370

1.05

0.09

1.2

1.3

6.81

6.09

mmol/l

1.63

351

Bacterial Sepsis

784

0.97

0.09

1.2

1.3

6.10

5.92

mmol/l

0.79

743

Congenital deformities of feet

1.09

0.09

1.3

1.5

5.20

5.79

mmol/l

—

Pneumococcal septicemia

1.07

0.08

1.7

1.4

5.83

6.19

mmol/l

—

Pneumonia derived septicemia

1.07

0.08

1.7

1.4

5.83

6.13

mmol/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

165

1.09

0.08

1.1

1.3

5.98

6.22

mmol/l

0.50

156

Anisometropia and aniseikonia

1.03

0.08

1.2

1.4

6.35

6.09

mmol/l

—

Renal failure

735

1.03

0.08

1.2

1.3

6.59

6.03

mmol/l

1.78

690

Mental and behavioural disorders due to psychoactive substance use

155

1389

1.02

0.08

1.3

1.4

5.86

5.66

mmol/l

1.27

146

1314

Arthropathies in other diseases classified elsewhere

1.09

0.08

1.0

1.3

6.01

5.81

mmol/l

—

Valvular heart disease excluding rheumatic fever

666

1.03

0.08

1.2

1.3

5.98

6.02

mmol/l

0.13

634

Other disorders of skin and subcutaneous tissue

189

1623

0.98

0.07

1.2

1.4

5.84

5.75

mmol/l

0.34

178

1528

Malignant neoplasm of stomach

1.07

0.07

1.1

1.2

5.72

6.43

mmol/l

—

Other and unspecified mood [affective] disorders

225

1.07

0.07

1.4

1.5

5.59

5.26

mmol/l

0.94

220

Agranulocytosis

225

1.07

0.07

1.5

1.3

7.12

5.87

mmol/l

0.85

214

All dysplastic lesions of the cervix uteri

111

1067

1.02

0.07

1.4

1.5

5.37

5.20

mmol/l

1.16

106

1019

Hyperhidrosis

0.84

0.07

1.1

1.5

5.90

5.52

mmol/l

—

Psoriasis

670

1.03

0.06

1.3

5.74

5.82

mmol/l

0.28

635

Other disorders of the musculoskeletal system and connective tissue

295

0.95

0.06

1.4

1.3

5.63

5.95

mmol/l

1.23

279

Dystonia

105

0.86

0.06

1.2

1.4

5.73

5.85

mmol/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

122

1166

1.02

0.06

1.4

1.5

5.37

5.25

mmol/l

0.78

115

1116

Injury of unspecified body region

148

1.08

0.06

1.1

1.4

5.65

5.77

mmol/l

0.18

141

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

111

0.90

0.06

1.4

5.92

6.05

mmol/l

—

105

Pneumonias (Asthma/COPD co-morbidities)

310

2046

0.99

0.06

1.3

1.4

5.79

5.56

mmol/l

2.73

285

1943

Organic, including symptomatic, mental disorders

653

1.02

0.06

1.2

1.3

6.28

6.10

mmol/l

0.62

611

External causes of morbidity and mortality

231

1142

1.01

0.06

1.4

5.65

5.48

mmol/l

0.83

219

1077

Hordeolum and other deep inflammation of eyelid

131

0.92

0.05

1.1

1.5

5.30

5.57

mmol/l

0.57

124

Purpura and other haemorrhagic conditions

283

0.95

0.05

1.5

1.4

5.52

5.77

mmol/l

0.95

271

Benign mammary dysplasia

303

0.96

0.05

1.4

1.3

5.34

5.69

mmol/l

1.78

286

Benign neoplasm of bone and articular cartilage

171

0.94

0.05

1.7

1.4

5.30

5.75

mmol/l

1.08

165

Injuries to the hip and thigh

103

940

0.98

0.05

1.3

5.84

5.85

mmol/l

0.03

882

Injuries to the shoulder and upper arm

230

1792

0.99

0.04

1.2

1.4

5.84

5.71

mmol/l

1.15

216

1690

Other respiratory diseases principally affecting the interstitium

292

0.96

0.04

1.4

1.3

5.96

6.17

mmol/l

0.44

273

Normotensive glaucoma

140

0.93

0.04

1.3

5.98

6.18

mmol/l

0.25

130

Non-rheumatic valve diseases

665

1.02

0.04

1.2

1.3

6.00

6.01

mmol/l

0.04

633

Ulcerative colitis (strict definition, all Crohn cases excluded)

352

0.97

0.04

1.2

1.4

5.29

5.60

mmol/l

1.21

335

Ptosis of eyelid

200

0.95

0.03

1.5

1.3

5.83

5.96

mmol/l

0.21

188

Examination and encounter for administrative purposes

121

1.07

0.03

1.1

1.3

6.60

6.23

mmol/l

0.32

116

Dermatitis

179

1768

0.99

0.03

1.4

5.52

5.68

mmol/l

1.22

163

1675

All pneumoniae

314

2053

0.99

0.03

1.3

1.4

5.77

5.56

mmol/l

2.35

289

1949

Sarcoidosis

240

1.04

0.03

1.3

5.94

5.96

mmol/l

0.02

229

Use of hypnotics and sedatives

315

1812

0.99

0.03

1.2

1.4

5.89

5.63

mmol/l

3.43

295

1714

Viral infections characterized by skin and mucous membrane lesions

114

1124

1.01

0.03

1.3

1.4

5.56

5.67

mmol/l

0.50

109

1062

Injuries to the thorax

103

1015

1.01

0.03

1.3

6.21

5.82

mmol/l

0.85

953

COPD, hospital admissions 1, only main diagnosis

488

1.02

0.03

1.3

1.2

6.31

6.12

mmol/l

0.18

460

Disorders of continuity of bone

211

1.04

0.03

1.5

1.4

5.76

5.74

mmol/l

0.03

201

Paralytic strabismus

112

1.07

0.03

1.2

1.3

6.00

6.10

mmol/l

0.13

107

Mental and behavioural disorders due to alcohol

121

1165

0.99

0.03

1.3

1.4

5.94

5.73

mmol/l

1.03

115

1104

Other viral diseases

815

1.01

0.02

1.3

1.4

5.49

5.43

mmol/l

0.13

774

Drug-induced neutropenia

132

1.06

0.02

1.5

1.3

7.00

5.94

mmol/l

0.71

124

Pneumonia, organism unspecified

271

1845

1.01

0.02

1.3

1.4

5.79

5.62

mmol/l

1.61

245

1751

Crohn disease

319

0.97

0.02

1.5

1.4

5.43

5.58

mmol/l

0.32

303

Substance abuse, excluding more controls

153

1289

0.99

0.02

1.3

1.4

5.88

5.56

mmol/l

2.58

144

1217

Alcohol use disorder, Swedish definition

125

1146

0.99

0.02

1.3

6.01

5.77

mmol/l

1.39

118

1088

Unspecified/other endometriosis

393

1.02

0.02

1.3

1.6

5.03

5.11

mmol/l

0.26

380

Postprocedural musculoskeletal disorders, not elsewhere classified

117

0.94

0.01

1.5

1.3

5.93

6.19

mmol/l

0.39

110

ILD medications: prednisolone, methylprednisolone, prednisone

345

1924

1.00

0.01

1.3

1.4

5.73

5.55

mmol/l

1.61

323

1826

Carcinoma in situ of cervix uteri

448

0.98

0.01

1.5

1.6

5.38

5.13

mmol/l

1.31

427

Other disorders of bladder

213

1.03

0.01

1.4

1.3

5.98

6.06

mmol/l

0.14

199

Other/unspecified synovitis and tenosynovitis

233

1.03

0.01

1.5

1.4

5.99

5.72

mmol/l

0.56

223

Disorders of ocular muscles, binocular movement, accommodation and refraction

148

1474

0.99

0.01

1.4

5.49

5.52

mmol/l

0.13

141

1395

Ulcer of oesophagus

106

0.94

0.01

1.0

1.2

6.43

6.02

mmol/l

—

101

Cerebral aneurysm, nonruptured

164

1.04

0.00

1.2

1.3

5.84

6.02

mmol/l

0.29

157

Palmar fascial fibromatosis [Dupuytren]

206

0.97

0.00

1.1

1.2

6.14

6.26

mmol/l

0.15

196

Atopic dermatitis

207

1653

1.00

0.00

1.5

1.4

5.18

5.49

mmol/l

5.40

197

1568

Other and unspecified dermatitis

150

1493

1.00

0.00

1.4

5.54

5.68

mmol/l

0.89

136

1412

Pacemaker

534

1.01

0.00

1.1

1.2

6.01

6.15

mmol/l

0.55

502

Interstitial lung disease

254

0.98

0.00

1.4

1.3

6.05

6.14

mmol/l

0.14

239

Other interstitial pulmonary diseases

254

0.98

0.00

1.4

1.3

6.05

6.14

mmol/l

0.14

239

Interstitial lung disease endpoints

254

0.98

0.00

1.4

1.3

6.05

6.14

mmol/l

0.14

239

Myocardial infarction, with ST-elevation

259

1.00

0.00

1.2

5.86

6.20

mmol/l

0.96

244

Fracture at wrist and hand level

844

1.00

0.00

1.3

1.4

5.63

5.66

mmol/l

0.12

796

Presbyopia

132

0.98

0.00

1.2

1.3

5.79

6.07

mmol/l

0.62

126

Spontaneous rupture of synovium and tendon

134

0.97

0.00

1.3

5.87

6.08

mmol/l

0.29

128

Intracranial trauma

173

1165

1.00

0.00

1.4

5.65

5.43

mmol/l

1.51

159

1103

Benign neoplasm: Descending colon

125

1.04

0.00

1.2

5.95

6.22

mmol/l

0.37

117

Vitamin B12 deficiency anaemia

174

0.98

0.00

1.2

1.3

6.87

6.09

mmol/l

0.81

165

ILD, hospital admissions 1, main diag only

225

1.02

0.00

1.3

6.05

6.13

mmol/l

0.12

210

Other disorders of the genitourinary system

235

1.02

0.00

1.3

5.36

6.00

mmol/l

2.59

219

Pain associated with micturition

255

0.98

0.00

1.3

1.4

5.82

5.75

mmol/l

0.13

242

Ulcerative colitis, NAS

335

1.02

0.00

1.3

1.4

5.57

5.63

mmol/l

0.12

317

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

303

2016

1.00

0.00

1.3

1.4

5.79

5.58

mmol/l

2.35

277

1913

Intracerebral haemorrhage

170

1.00

0.00

1.0

1.3

6.15

6.20

mmol/l

0.08

161

Diplopia

276

1.01

0.00

1.5

1.3

5.63

5.85

mmol/l

0.62

264

Acne vulgaris

290

1.00

0.00

1.4

1.6

5.25

5.06

mmol/l

0.43

276

Spermatocele

101

0.99

0.00

1.1

1.3

5.95

6.55

mmol/l

—

ILD, hospital admissions

251

1.00

0.00

1.4

1.3

6.05

6.13

mmol/l

0.13

236

Other superficial mycoses, including avohilmo

291

1.00

0.00

1.3

1.5

5.42

5.41

mmol/l

0.01

280

Malignant neoplasm of rectum

156

1.03

0.00

1.1

1.3

5.97

6.20

mmol/l

0.40

147

Malignant neoplasm of rectum, including Hilmo

202

0.99

0.00

1.2

1.3

6.13

6.22

mmol/l

0.15

191

Vascular disorders of the intestines

103

0.97

0.00

1.2

6.65

6.21

mmol/l

—

Injuries to unspecified part of trunk, limb or body region

208

1.01

0.00

1.0

1.4

5.55

5.77

mmol/l

0.49

199

Carcinoma in situ of skin of lip

0.00

0.0

1.0

—

10.42

—

Malignant neoplasm of penis

0.00

0.0

1.3

—

9.90

—

Knuckle pads

0.00

0.0

1.3

—

9.63

—

Benign neoplasm: Vertebral column

0.00

0.0

1.0

—

6.23

—

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.0

1.0

—

9.14

—

Osteopathy in diseases classified elsewhere

0.00

0.0

1.1

—

9.20

—

Benign neoplasm: Floor of mouth

0.00

0.0

1.2

—

6.53

—

Exposure to ignition of highly flammable material

0.00

0.0

1.1

—

9.19

—

Familial erythrocytosis

0.00

0.0

1.0

—

8.81

—

Livedoid vasculitis

0.00

0.0

1.0

—

10.62

—

Malignant neoplasm of anus and anal canal

0.00

0.0

1.1

—

6.33

—

Other and unspecified water transport accidents

0.00

0.0

1.0

—

8.67

—

Benign neoplasm: Scrotum

0.00

0.0

1.3

—

8.91

—

Malignant neoplasm of gum

0.00

0.0

1.1

—

8.91

—

Femoral hernia, bilateral

0.00

0.0

1.0

—

8.74

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

0.00

0.0

1.2

—

9.60

—

Implicit parasitic Sepsis

0.00

0.0

1.3

—

8.47

—

Other hypertrichosis

0.00

0.0

1.2

—

5.30

—

Injury of nerves and spinal cord at thorax level

0.00

0.0

1.1

—

6.04

—

Renal agenesis and other reduction defects of kidney

0.00

0.0

1.2

—

5.98

—

Other infiltrative disorders of skin and subcutaneous tissue

0.00

0.0

1.1

—

8.81

—

Injury of blood vessels at abdomen, lower back and pelvis level

0.00

0.0

1.0

—

10.00

—

Abnormal pulmonary venous return

0.00

0.0

1.0

—

6.00

—

Blindness or visual impairment, binocular

0.00

0.0

1.2

—

6.64

—

Acute hepatitis A, including avohilmo

0.00

0.0

1.0

—

8.90

—

Idiopathic hypoparathyroidism

0.00

0.0

1.2

—

9.28

—

Other degenerative disorders of eyelid and periocular area

0.00

0.0

1.2

—

6.60

—

Alcoholic cardiomyopathy

0.00

0.0

1.2

—

8.61

—

Other and unspecified neuropathies

0.00

0.0

1.0

—

6.12

—

Injury of blood vessels at lower leg level

0.00

0.0

1.0

—

6.46

—

Other specified/unspecified diseases of inner ear

0.00

0.0

1.0

—

6.24

—

Other effects of reduced temperature

0.00

0.0

1.0

—

6.38

—

Other congenital malformations of brain

0.00

0.0

1.3

—

5.35

—

Other and unspecified medical devices associated with adverse incidents

0.00

0.0

1.1

—

8.74

—

Drug-induced gout

0.00

0.0

1.0

—

10.38

—

Congenital malformations of great veins

0.00

0.0

1.4

—

5.78

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

0.00

0.0

1.1

—

6.08

—

Systemic disorders of connective tissue in diseases classified elsewhere

0.00

0.0

1.0

—

6.33

—

Cardiomyopathy in other diseases

0.00

0.0

1.0

—

9.06

—

Rare circulating lymphoid malignancy

0.00

0.0

1.1

—

8.97

—

Malignant neoplasm of gallbladder

0.00

0.0

1.2

—

9.43

—

Amoebiasis

0.00

-0.00

0.0

1.1

—

8.18

—

Enterobiasis

0.00

-0.00

0.0

1.3

—

5.62

—

Vascular dementia (other)

0.00

-0.00

0.0

1.1

—

6.54

—

Carcinoma in situ of middle ear and respiratory system

0.00

-0.00

0.0

1.1

—

6.18

—

Secondary systemic amyloidosis

0.00

-0.00

0.0

1.0

—

6.15

—

Moderate mental retardation

0.00

-0.00

0.0

1.1

—

9.09

—

Glaucoma secondary to drugs

0.00

-0.00

0.0

1.0

—

9.80

—

Cholinergic urticaria

0.00

-0.00

0.0

1.2

—

5.58

—

Enduring personality changes

0.00

-0.00

0.0

1.0

—

5.76

—

Cardiomyopathies, Secondary/extrinsic

0.00

-0.00

0.0

1.1

—

8.52

—

Marasmic kwashiorkor

0.00

-0.00

0.0

1.0

—

6.34

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

-0.00

0.0

1.3

—

5.45

—

Contact urticaria

0.00

-0.00

0.0

1.1

—

5.87

—

Hypertensive encephalopathy

0.00

-0.00

0.0

1.2

—

6.51

—

Histrionic personality disorder

0.00

-0.00

0.0

1.0

—

5.92

—

Oher contracture of tendon (sheath)

0.00

-0.00

0.0

1.2

—

9.98

—

Acanthosis nigricans

0.00

-0.00

0.0

1.2

—

5.68

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

-0.00

0.0

1.4

—

5.11

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

-0.00

0.0

2.1

—

4.84

—

Other and unspecified parapsoriasis

0.00

-0.00

0.0

1.0

—

9.80

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

-0.00

0.0

1.0

—

8.67

—

Perforation of oesophagus

0.00

-0.00

0.0

1.1

—

6.14

—

Atrioventricular septal defect

0.00

-0.00

0.0

1.3

—

5.98

—

Carcinoma in situ of breast

0.00

-0.00

0.0

1.0

—

5.77

—

Other and unspecified atrophic disorders of skin

0.00

-0.00

0.0

1.4

—

5.66

—

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

0.00

-0.00

0.0

1.0

—

8.61

—

Syndrome of inappropriate secretion of antidiuretic hormone

0.00

-0.00

0.0

1.0

—

8.87

—

Disorders of puberty, other/unspecified

0.00

-0.00

0.0

1.6

—

5.03

—

Lipomatosis, not elsewhere classified

0.00

-0.00

0.0

1.0

—

6.03

—

Rheumatic fever with heart involvement

0.00

-0.00

0.0

1.0

—

6.21

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

-0.00

0.0

1.0

—

6.50

—

Alpha thalassaemia

0.00

-0.00

0.0

1.3

—

6.07

—

Foreign body in respiratory tract

0.92

-0.00

1.3

1.4

5.02

5.91

mmol/l

—

Vitreous prolapse

0.00

-0.00

0.0

1.0

—

5.64

—

Benign neoplasm: Lower jaw bone

0.00

-0.00

0.0

1.0

—

6.29

—

Lymphangioma, anys site

0.00

-0.00

0.0

1.1

—

5.88

—

Neuroendocrine tumor and carcinoma of stomach

0.00

-0.00

0.0

1.2

—

9.52

—

Malignant neoplasm of other and ill-defined digestive organs

0.00

-0.00

0.0

1.1

—

8.71

—

Neuroendocrine tumor and carcinoma of rectum

0.00

-0.00

0.0

1.2

—

6.33

—

0.00

-0.00

0.0

1.3

—

6.53

—

Family history of mental and behavioural disorders

0.00

-0.00

0.0

1.0

—

9.86

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

-0.00

0.0

1.2

—

9.93

—

Left side

0.00

-0.00

0.0

1.2

—

10.28

—

0.00

-0.00

0.0

1.0

—

5.87

—

Right side

0.00

-0.00

0.0

1.2

—

9.82

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

-0.00

0.0

1.0

—

9.26

—

Nonadministration of surgical and medical care

0.00

-0.00

0.0

1.0

—

6.01

—

Intentional self-harm by smoke, fire and flames

0.00

-0.00

0.0

1.0

—

6.36

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

-0.00

0.0

1.0

—

10.13

—

Foreign object accidentally left in body during surgical and medical care

0.00

-0.00

0.0

1.3

—

8.40

—

Exposure to controlled fire, not in building or structure

0.00

-0.00

0.0

1.0

—

6.48

—

Intentional self-harm by sharp object

0.95

-0.00

1.7

1.4

5.20

5.59

mmol/l

—

Inhalation of gastric contents

0.00

-0.00

0.0

1.0

—

9.47

—

Exposure to uncontrolled fire, not in building or structure

0.00

-0.00

0.0

1.1

—

8.95

—

Contact with blunt object, undetermined intent

0.00

-0.00

0.0

1.1

—

8.51

—

Vascular dementia (sudden onset)

0.00

-0.00

0.0

1.0

—

6.68

—

Traumatic amputation of lower leg

0.00

-0.00

0.0

1.1

—

9.24

—

Tracheo-bronchomalasia

0.00

-0.00

0.0

1.5

—

4.78

—

Injury of blood vessels at hip and thigh level

0.00

-0.00

0.0

1.0

—

9.94

—

Injury of blood vessels at forearm level

0.00

-0.00

0.0

1.4

—

6.08

—

Injury of blood vessels of thorax

0.00

-0.00

0.0

1.2

—

6.42

—

Crushing injury of forearm

0.00

-0.00

0.0

1.4

—

6.36

—

Effects of air pressure and water pressure

0.00

-0.00

0.0

1.0

—

8.60

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.2

—

10.50

—

Complications following myocardial infarction

0.00

-0.00

0.0

1.1

—

8.85

—

Corrosions classified according to extent of body surface involved

0.00

-0.00

0.0

1.0

—

5.88

—

Pectus excavatum

0.00

-0.00

0.0

1.4

—

7.69

—

Other congenital musculoskeletal deformities

0.00

-0.00

0.0

1.3

—

5.32

—

Other congenital musculoskeletal deformities, including avohilmo

0.00

-0.00

0.0

1.3

—

5.47

—

Cachexia

0.00

-0.00

0.0

1.4

—

8.68

—

Other and unspecified abdominal hernia

0.94

-0.00

1.5

1.3

5.92

6.25

mmol/l

—

Renal agenesis and other reduction defects of kidney, including avohilmo

0.00

-0.00

0.0

1.1

—

5.89

—

Congenital aortic valve stenosis

0.00

-0.00

0.0

1.7

—

8.60

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

-0.00

0.0

1.6

—

4.96

—

Reduction defects of upper limb, including avohilmo

0.00

-0.00

0.0

1.2

—

5.35

—

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

0.00

-0.00

0.0

1.6

—

4.96

—

Marfan's syndrome

0.00

-0.00

0.0

1.1

—

5.91

—

Congenital dislocation of hip, unilateral

0.00

-0.00

0.0

1.1

—

5.77

—

Cleft lip and palate

0.00

-0.00

0.0

1.0

—

6.15

—

Congenital absence of the uterus

0.00

-0.00

0.0

1.0

—

5.56

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

-0.00

0.0

1.2

—

4.92

—

Rapidly progressive nephritic syndrome

0.00

-0.00

0.0

1.0

—

6.48

—

Use of riluzole

0.00

-0.00

0.0

1.0

—

6.37

—

Progressive systemic sclerosis

0.00

-0.00

0.0

1.0

—

8.28

—

Other specified acquired deformities of limbs

0.00

-0.00

0.0

1.4

—

6.11

—

Osteomyelitis of vertebra

0.00

-0.00

0.0

1.2

—

10.68

—

Kissing spine

0.00

-0.00

0.0

1.2

—

6.52

—

Acquired atrophy of ovary and fallopian tube

0.00

-0.00

0.0

1.5

—

5.27

—

Radiodermatitis

0.00

-0.00

0.0

1.0

—

5.95

—

Erythema in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

5.73

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

8.81

—

Liver disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

5.59

—

Pneumonia due to Haemophilus influenzae

0.00

-0.00

0.0

1.2

—

10.79

—

Malignant neoplasm of palate, including Hilmo

0.00

-0.00

0.0

1.3

—

8.86

—

Hypertension, portal

0.00

-0.00

0.0

1.0

—

9.20

—

Otorrhagia

0.00

-0.00

0.0

1.1

—

8.53

—

Collapsed vertebra, not elsewhere classified

0.00

-0.00

0.0

1.2

—

6.56

—

Peripheral retinal degeneration

1.00

-0.00

1.2

1.4

5.53

6.29

mmol/l

—

Endometriosis of intestine

0.91

-0.00

1.0

1.5

5.02

5.15

mmol/l

—

Other specified/unspecified disorders of ear

0.00

-0.00

0.0

1.1

—

8.54

—

Juvenile cataract

0.00

-0.00

0.0

1.0

—

8.78

—

Other and unspecified disorders of lacrimal system

0.00

-0.00

0.0

1.0

—

6.04

—

Mild or no visual impairment, binocular

0.00

-0.00

0.0

1.0

—

9.06

—

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

0.00

-0.00

0.0

1.2

—

6.40

—

Other and unspecified disorders of orbit

0.00

-0.00

0.0

1.0

—

6.43

—

Lesion of medial popliteal nerve

0.00

-0.00

0.0

1.2

—

9.93

—

Food allergy

0.00

-0.00

0.0

1.0

—

5.82

—

Sleepwalking [somnambulism]

0.00

-0.00

0.0

1.3

—

5.71

—

Disorders of other and unspecified cranial nerves

0.00

-0.00

0.0

1.3

—

6.39

—

Mental and behavioural disorders due to hallucinogens

0.00

-0.00

0.0

1.5

—

5.99

—

Disorders of purine and pyrimidine metabolism

0.00

-0.00

0.0

1.0

—

8.38

—

Hypersensitivity angiitis

0.00

-0.00

0.0

1.0

—

6.77

—

Pituitary-dependent Cushing's disease

0.00

-0.00

0.0

1.0

—

5.94

—

Magnesium deficiency

0.00

-0.00

0.0

1.1

—

9.27

—

Thyrotoxicosis factitia

0.00

-0.00

0.0

1.0

—

6.21

—

Carcinoma in situ of endometrium

0.00

-0.00

0.0

1.0

—

5.91

—

Hypothyroidism, autoimmune, DX-based

0.00

-0.00

0.0

1.1

—

5.82

—

Central nervous system disorder causing precocious puberty

0.00

-0.00

0.0

1.7

—

4.95

—

Alkalosis

0.00

-0.00

0.0

1.2

—

6.23

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

0.00

-0.00

0.0

1.0

—

10.34

—

Nondiabetic hypoglycaemic coma

0.00

-0.00

0.0

1.2

—

5.71

—

Acute drug-induced interstitial lung disorder

0.00

-0.00

0.0

1.0

—

8.51

—

0.00

-0.00

0.0

1.1

—

8.25

—

Fluid overload

0.00

-0.00

0.0

1.0

—

6.37

—

Myotonic dystrophy (Steinert)

0.00

-0.00

0.0

1.0

—

8.76

—

Other and unspecified diseases of spleen

0.00

-0.00

0.0

1.0

—

8.69

—

Organ-limited amyloidosis

0.00

-0.00

0.0

1.0

—

6.37

—

Congenital hypothyroidism without goiter

0.00

-0.00

0.0

1.3

—

5.63

—

Adrenogenital disorders

0.00

-0.00

0.0

1.0

—

6.18

—

Disseminated intravascular coagulation [defibrination syndrome]

0.00

-0.00

0.0

1.1

—

6.09

—

Congenital hydrocephalus

0.00

-0.00

0.0

1.3

—

5.91

—

Pectus excavatum, including avohilmo

0.00

-0.00

0.0

1.4

—

7.69

—

Benign neoplasm: Thymus

0.00

-0.00

0.0

1.2

—

5.95

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

-0.00

0.0

1.0

—

6.19

—

Benign neoplasm: Prostate

0.00

-0.00

0.0

1.3

—

9.36

—

Benign neoplasm: Pineal gland

0.00

-0.00

0.0

1.4

—

5.30

—

Benign neoplasm: Lymph nodes

0.00

-0.00

0.0

1.2

—

6.12

—

Benign neoplasm: Epididymis

0.00

-0.00

0.0

1.1

—

9.47

—

Selective deficiency of immunoglobulin A [IgA]y

0.00

-0.00

0.0

1.2

—

9.85

—

Pseudomembranous colitis

0.00

-0.00

0.0

1.0

—

5.87

—

Mucinous and mucinous cystic tumor of rectum

0.00

-0.00

0.0

1.2

—

10.79

—

Malignant neoplasm of nasopharynx

0.00

-0.00

0.0

1.1

—

8.95

—

Malignant neoplasm of thymus, including Hilmo

0.00

-0.00

0.0

1.2

—

6.09

—

Disorders of amino-acid transport

0.00

-0.00

0.0

1.0

—

10.05

—

Malignant neoplasm of palate

0.00

-0.00

0.0

1.2

—

10.34

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

-0.00

0.0

1.3

—

9.63

—

Osteosarcoma

0.00

-0.00

0.0

1.2

—

6.43

—

Malignant neoplasm of penis, including Hilmo

0.00

-0.00

0.0

1.3

—

9.90

—

Granulosa cell carcinoma of ovary

0.00

-0.00

0.0

1.2

—

5.24

—

Osteosarcoma, including Hilmo

0.00

-0.00

0.0

1.2

—

6.43

—

Malignant neoplasm of hypopharynx, including Hilmo

0.00

-0.00

0.0

1.2

—

8.58

—

Malignant neoplasm of nasopharynx, including Hilmo

0.00

-0.00

0.0

1.3

—

8.46

—

Chromophobe cell carcinoma of kidney

0.00

-0.00

0.0

1.3

—

8.90

—

Adenocarcinomas of cervix

0.00

-0.00

0.0

1.1

—

5.22

—

Hydrocephalus in other diseases

0.00

-0.00

0.0

1.0

—

8.26

—

Meretoja disease

0.00

-0.00

0.0

1.2

—

10.42

—

Congenital lactase deficiency

0.00

-0.00

0.0

1.2

—

5.71

—

Maze procedure for atrial fibrillation

0.00

-0.00

0.0

1.1

—

9.49

—

Other specified/unspecified nutritional deficiencies

0.00

-0.00

0.0

1.0

—

6.47

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

0.00

-0.00

0.0

1.0

—

9.14

—

Benign neoplasm: Connective and other soft tissue of thorax

0.00

-0.00

0.0

1.0

—

6.27

—

Benign neoplasm: Hypopharynx

0.00

-0.00

0.0

1.2

—

9.68

—

Malignant neoplasm of floor of mouth

0.00

-0.00

0.0

1.2

—

10.76

—

Benign neoplasm: Heart

0.00

-0.00

0.0

1.0

—

8.42

—

Other facial nerve disorders

0.93

-0.00

1.2

1.4

5.80

6.18

mmol/l

—

Allergic bronchopulmonary aspergillosis (ABPA)

0.00

-0.00

0.0

1.0

—

6.11

—

Malignant neoplasm of base of tongue

0.00

-0.00

0.0

1.5

—

8.59

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.8

—

9.62

—

Listeriosis

0.00

-0.00

0.0

1.0

—

10.34

—

Acute hepatitis A

0.00

-0.00

0.0

1.0

—

8.89

—

Erysipeloid, including avohilmo

0.00

-0.00

0.0

1.2

—

6.15

—

Intestinal helminthiases, other/unspecified, including avohilmo

0.00

-0.00

0.0

1.0

—

6.04

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

-0.00

0.0

1.2

—

10.90

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

0.00

-0.00

0.0

1.1

—

6.04

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

-0.00

0.0

1.1

—

6.11

—

Actinomycosis, including avohilmo

0.00

-0.00

0.0

1.2

—

10.22

—

Congenital retinoschisis

0.00

-0.00

0.0

1.0

—

6.26

—

Listeriosis, including avohilmo

0.00

-0.00

0.0

1.0

—

10.34

—

Injury of blood vessels at neck level

0.00

-0.00

0.0

1.1

—

6.21

—

Other disorders of amino-acid metabolism

0.00

-0.00

0.0

1.0

—

8.80

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glucose [Moles/volume] in Serum or Plasma --baseline

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS